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Abstract
Kidins220 (Kinase-D interacting substrate of 220 kDa) is a scaffold transmembrane
protein abundantly expressed in the nervous system. Mutations in the KIDINS220
gene have been correlated with psychiatric disorders and with the recently described
SINO syndrome, characterized by spastic paraplegia, intellectual disability, syntag-
mus and obesity. Kidins220 is involved in several neuronal functions regulated by
neurotrophic factors, including neuronal survival, differentiation and synaptic plas-
ticity. Previous work with the complete KO mouse model for Kidins220 evidenced
the crucial role of this protein in neuronal and cardiovascular development since its
embryonic ablation is lethal. Thus to gain a comprehensive understanding of the
role of Kidins220 in the adult mouse, a Cre/loxP based conditional KO (cKO) mouse
model was generated, in which the Ca2+/ Calmodulin-dependent kinase-II (CaMKII)
promoter drives Cre expression, and consequently protein deletion specifically in the
postnatal forebrain. The characterization of the Kidins220 cKO model has been ac-
complished through diverse approaches: behavioural experiments, brain and neuron
morphological analysis, molecular signalling from brain slices and cultures, protein
and gene expression assessment. cKO mice display alterations in anxiety levels and
social behaviour, with a clear impairment in social memory. At the morphological
level, data show reduced dendritic branching in cortical and hippocampal neurons,
while at the molecular level, neuronal response to brain-derived neurotrophic fac-
tor (BDNF) stimulation is blunted, as well as the mitogen-activated protein kinase
(MAPK) pathway activation. The behavioural profile of these animals provides use-
ful knowledge about the pathophysiology of Kidins220, indicating that alterations of
this protein expression may have important consequences on human pathologies
of the cognitive and social sphere. Some psychiatric diseases are highly inherita-
ble, and their causes have been traced back to genetic alterations such as point
mutations and epigenetic modifications. A better understanding of such inheritable
traits will provide us with a better knowledge of the cellular and physiological alter-
ations underlying the behavioural and cognitive symptomatology of patients. In this
respect, the knowledge of Kidins220 function will contribute to further elucidate the
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Kidins220 (Kinase D-interacting substrate of 220kDa) / ARMS (Ankyrin repeat-rich
membrane spanning), hereby referred to as Kidins220, was identified as the first
physiological Kinase D substrate in neural cells [1] ] and as a novel downstream
target of neurotrophin and ephrin receptor tyrosine kinases [2]. Kidins220 is a trans-
membrane scaffold protein ubiquitously expressed with a higher expression in the
nervous system [1,2]. Its sequence is highly conserved across species [2], enabling
the study of Kidins220 with animal models. In the mouse nervous system, Kidins220
expression is modulated across development: the maximum protein expression oc-
curs at birth and decreases over the first month, after which it remains constant [3].
Kidins220 is expressed in the entire mouse brain, with a more prominent concentra-
tion in the cortex and the hippocampus. Specifically, in the cortex, a high expression
of this protein is found in pyramidal neurons of Layer 5 in both cell bodies and den-
dritic projections. In the hippocampus, it is found in the somas of the neurons of all
hippocampal areas and in the dendrites of the molecular layer cells of the dentate
gyrus [4].
I.II Kidins220 structure and protein interactions
Kidins220 is a transmembrane scaffold protein comprised of multiple protein inter-
action domains (Figure 1), which are located in the N-terminal and C-terminal cyto-
plasmic tails, and in the four transmembrane domains [1].
I.II.1 Ankyrin repeats
Ankyrin repeats are the most widely expressed protein motifs in nature and consist
of 30-34 amino acid residues with the exclusive function of mediating protein-protein
interactions [5]. The proteins which interact with Kidins220 via these domains are
the following (see Figure 1):
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Trio: this is a RhoGEF (guanine nucleotide exchange factor) that activates
the GTPases (guanine triphosphatase) Rac1 and RhoG, which mediate cy-
toskeletal remodelling. Via its interaction with Kidins220, Trio promotes neurite
outgrowth by activating these GTPases [6].
MAP1b (microtubule associated protein 1b): as its own name indicates, MAP1b
is a factor that acts directly on microtubules to stabilize them. It is especially
prominent in extending axons and their growth cones. Amongst its several
functions, MAP1b modulates the stable anchoring of AMPA receptors to mi-
crotubules, and consequently their intracellular trafficking. Overexpression of
MAP1B leads to a decrease in the number of AMPAR at the synapse [7].
Through its interaction with Kidins220, MAP1b regulates early axonal outgrowth
and the establishment of neuronal polarity by modulating microtubule dynam-
ics [8].
SCG10 (superior cervical ganglion 10) and Sclip (Scgn10 like-protein): these
are tubulin-regulating proteins of the stathmin family, exclusively expressed in
the nervous system. They interact with Kidins220 in the perinuclear region and
the growth cones, to facilitate the early stages of neural differentiation [9].
The specific interaction of Kidins220 with MAP1b and the two stathmin pro-
teins and its ability to modify their activity place Kidins220 in a privileged position to
coordinate their regulatory role on microtubule dynamics during neuronal polariza-
tion and development [9].
I.II.2 Transmembrane domains
Kidins220 transmembrane domains allow its interaction with tropomyosin-related ki-
nase (Trk) receptors [2].
TrkA: Kidins220 interacts with this receptor upon nerve growth factor (NGF)
stimulation. The disruption of this interaction results in aborted NGF-dependent
signal transduction critical for neurite outgrowth [10].
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TrkB: this receptor is specifically activated by the brain-derived neurotrophic
factor (BDNF) and neurotrophin 4/5 (NT4/5), after which it interacts with the
transmembrane domain of Kidins220 and phosphorylates a specific residue in
its cytoplasmic C-terminal tail [2, 10]. In addition, Lopez-Benito et al. have
recently shown that Kidins220 negatively regulates the secretion of BDNF [11].
TrkC: this receptor is activated upon interaction with NT 3 (neurotrophin 3).
Kidins220 does interact with this receptor [10], however, the functional conse-
quences of this interaction are still not described.
Kidins220 also associates with the GluA1 subunit of AMPA receptors through its
transmembrane domains, modulating neuronal activity. Decreasing Kidins220 re-
sults in a remarkable increase of basal transmission, coupled with alterations in the
phosphorylation and surface expression of GluA1-containing AMPAR [12].
I.II.3 Poly-proline stretch
This protein-interaction domain is located in the C-terminus of Kidins220 and is
known to interact with the adaptor protein CrkL (Crk-like protein) via its SH3 (SRC
Homology 3) domain constitutively. Interestingly, upon the Trk receptor-mediated
phosphorylation of tyrosine1096 (residue situated within the poly-proline sequence),
CrkL binds to Kidins220 through its SH2 domain. This switch in the binding require-
ment would allow for the release of the SH3 domain of CrkL to recruit C3G and Rap1
and trigger MAPK sustained activation [13]. Peculiarly, Kidins220 is one of the few
proteins specifically required for sustained MAPK signalling activation [6], which re-
sults in neurite branching. Most of the other elements of the pathway are involved in
transient signalling, which entails neurite elongation, as well [14].
I.II.4 Sterile-α Motif (SAM)
The SAM domain present in the C-terminal of Kidins220 is one of the most con-
served protein interaction domains across species [2]. This domain is arranged in a
small five-helix bundle with two large interfaces able to undergo homo- and hetero-
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oligomerization as well as polymerization thus forming different types of protein ar-
chitecture. To date, it is unknown which proteins, if any, interact with Kidins220 by
way of SAM.
I.II.5 Kinesin-Interacting domain (KIM)
The intracellular trafficking of Kidins220 is mediated through a direct binding of KIM
to KLC-1 (Kinesin light chain-1) and KLC-2, which are subunits of Kinesin-1. The
Kinesin-1 family of molecular motors is implicated in the transport of an increasing
number of proteins [15]. KIM overexpression reduces NGF-dependent differentiation
of rat pheochromocytoma (PC12) cells, thus suggesting that Kidins220 transport
by Kinesin-1 plays a role in the NGF-triggered sustained activation of the MAPK
pathway, and subsequent cell differentiation [16].
I.II.6 PDZ domain
The PDZ domain is a structural domain consisting of 80-90 amino acid residues
localized in signalling proteins. PDZ is an acronym combining the first letters of the
first three proteins identified to contain this motif (post-synaptic density 95, discs
large, zona ocludens-1). The PDZ sequence is instrumental in anchoring various
receptors to specific domains of the cell membrane by binding the receptors to the
cytoskeleton [17]. By its PDZ-binding sequence, Kidins220 interacts with various
proteins:
α-and β-syntrophin are scaffold proteins of the sarcolemma of skeletal mus-
cle, at the neuromuscular junction. Syntrophins are diffusely distributed in the
sarcolemma during early postnatal stages. Later in development, they become
gradually concentrated at the postsynaptic junction sites. α-syntrophin plays an
important role in the regulation of Kidins220 localization during the neuromus-
cular junction differentiation. It is likely that α-syntrophin works as a scaffold
protein for enhancing Eph signalling by recruiting protein complexes to a spe-
cific subcellular localization, such as sub-synaptic regions in muscle [18].
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Pdzm3 is a protein involved in early neurogenesis. PDZM 3 and KIDINS220
genes show overlapping expression domains in the hindbrain, ventral retina
and motor neurons of zebrafish. The small patch of retinal precursors that ex-
press both genes at stage 32 h post-fertilization corresponds to the first post-
mitotic cells that differentiate to form ganglion cells with axons extending to-
wards the optic fissure and dendrites branching in the inner retina [19].
S-SCAM (synaptic scaffolding molecule) forms a tetrameric complex with Trk
receptors, Kidins220 and the Rap1 activator through the PDZ domain present
in S-SCAM and the PDZ-binding sequence of Kidins220, to achieve sustained
ERK stimulation [15]. The function of N-methyl-D-aspartate receptors (NM-
DARs) requires the participation of large and dynamic signalling complexes
whose formation mainly depends on C-terminal domains, including PDZ-binding
motifs present in most NR2 and NR1 (NMDA receptor subunits 1 and 2). Out
of the 6 PDZ domains contained in S-SCAM, PDZ5 binds directly to NM-
DAR subunits, whereas PDZ4 mediates the interaction with Kidins220. Con-
sequently, S- SCAM might also participate in the association of Kidins220 and
the NMDARs. Over-activation of NMDARs induces a dramatic downregulation
of Kidins220 both in vitro and in vivo. Kidins220 undergoes a comparable reg-
ulation in a model of cerebral ischemia, in which NMDARs are over-activated
by glutamate pathologically released from neurons in the ischemic core [20].
SNX27 (sortin nexin 27) is a protein involved in the retrograde transport of en-
dosomes, which specifically binds and directs sorting of PDZ-containing trans-
membrane proteins, preventing the entry into the lysosomal pathway. This pro-
tein interacts with Kidins220 averting the 2-adrenergic receptor degradation
during its recycling cycle [21].
p75NTR is a neurotrophin receptor with the potential to dimerize with monomers
of any of the three Trk receptors and it interacts with Kidins220 throughout the C-
terminal tail. It preferentially binds to proneurotrophins so p75 has the faculty of
activating two major pathways [22]:
1. JNK (Jun Kinase) signalling pathway: leads to apoptosis through the activation
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5 of p53, a cell cycle regulating protein. In neuronal populations, this pathway
leads to apoptosis [20].
2. NF-kB (Nuclear factor kappa-light-chain enhancer of activated B cells) sig-
nalling pathway: promotes neuronal survival [23, 24] by means of the release
of the transcription factor NF-kB that leads to the transcription of pro-survival
proteins and cytokine production.
A common feature of Kidins220, p75, TrkA and Eph receptors is that they
all contain putative C-terminal PDZ-binding motifs. It is, therefore, possible that
these proteins are localized to the same subcellular compartment by PDZ domain-
containing molecules, and this localization may contribute to signalling events both in
development and in adulthood. Kidins220 and p75 expression overlap in adult most
notably in the olfactory bulb, Purkinje cells of the cerebellum, and motor neurons of
the spinal cord [2].
I.III Protein interactions with undefined interacting domains
I.III.1 Protein Kinase-D
Kidins220 owes its name to being the first endogenous substrate of PKD, identified
by Iglesias and colleagues [1]. PKD is a serine/threonine kinase distantly related to
the PKC family. In cells, DAG (diacylglycerol) and activation of PKC activate PKD
[25]. PKD is involved in diverse cellular processes like cell migration, differentiation
and polarization [25]. Active PKD is constitutively associated with lipid rafts, which
serve as a platform for the signalling cascades triggered by NGF through p75 and
TrkA. Activation of these receptors within lipid rafts could result in Kidins220 tyrosine
phosphorylation and in signal propagation through this membrane compartment [26].
I.III.2 Proteins involved in the immune system
T-cell receptor (TCR) and B-Raf interact with Kidins220 promoting sustained Erk ac-
tivation [26]. Kidins220 interacts with resting and activated B-cell antigen receptor
6
(BCR) regulating its signalling, which is critical for B-lymphocyte development, prolif-
eration and activation [27].
Kidins220 is an important component of the uropod, the hind part of motile
immune cells, where it establishes associations with critical T-cell uropod compo-
nents. As T-cell polarizes Kidins220, which is initially dispersed on the plasma mem-
brane, becomes highly concentrated at the rear end of the cell, where it co-localizes
with proteins normally associated to this structure, such as Intercellular Adhesion
Molecule 3 (ICAM-3) and caveolin-1 [28].
Dendritic cells undergo a process of maturation and migration to the lymph
nodes where they present antigens to T-cells. The modules and motifs in the cy-
toplasmic regions of Kidins220 may link this protein to the regulation of the motile
processes of dendritic cells and neurons [29].
HIV Tat-induced activation of NF-kB signalling occurs through the interaction
between the Inhibitory Kappa B Kinase (IKK) complex and Kidins220 in microglia
[30].
I.III.3 Proteins involved in the cardiovascular system development
Kidins220 constitutively binds to vascular endothelial growth factor receptor (VEGFR)
having a key role in angiogenesis. Kidins220−/− embryos display severe cardiovas-
cular deformities, with abnormal heart morphology [31].
I.III.4 Septin-5
Septins are known to play key roles in supporting cytoskeletal stability, vestibular
transport, and endo/exocytosis, stabilizing cellular membranes and forming diffusion
barriers [32]. Kidins220 interacts with Septin-5 (CDCrel-1) a member of a highly
conserved family of GTP-binding proteins [33]. The role of mammalian septins is not
clearly elucidated but it has been reported that Sept-5 inhibits exocytosis by binding
to syntaxin 1A [34, 35]. Sept-5 is also accumulated in large amounts at the plasma
membrane and at the tips of neurites in NGF-treated PC12 cells [34].
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I.III.5 Nav1.2 channel
Voltage-gated sodium (Nav) channels are responsible for the initiation of action po-
tential at the axonal initial segment. Nav channels are fundamental players in all
kinds of neuronal communications. They are multimeric complexes of α and β sub-
units that exist in several isoforms. The specific channel localization is determined
by the interaction of their subunits with a set of adhesion molecules, as well as cy-
toskeletal and extracellular matrix proteins. There is a higher Na+ conductance in
hippocampal Kidins220−/− GABAergic neurons, which might be due to the interac-
tion between Kidins220 and the Nav1.2 subunit. This interaction gains importance
in view of the well-established connection between BDNF signalling and neuronal
excitability [36].
Figure 1. Kidins220 and its interacting proteins. (modified from [37])
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I.IV Kidins220 isoforms
Schmieg and colleagues [38] published a work in which the diverse Kidins220 splice
isoforms were described for the first time. In fact the existence of alternative splice
isoforms provides an explanation to the diverse functions and localization of this
protein in different systems of the organism In total, 6 isoforms were identified in the
central region and 3 isoforms at the C-terminal in mice, while 3 isoforms in the central
region and 3 at the C-terminal are present in humans (see Figure 2). The reduced
number of splice isoforms found in humans is due to the fact that exons 27 and 28
are undetectable in the human genome.
Alternative splice isoforms of Kidin220 lacking exons 24-29 are present in
adult mouse and human tissues. Because of the severe phenotypes described in
the nervous and cardiovascular systems of full Kidins220 KO embryos, which led
to embryonic death, the presence of the different isoforms was especially studied
in brain, heart and motor neurons. In the mouse brain, isoforms m1, m2, m4, m5
and m6, were recognized. The three human isoforms were detected in brain tissue
as well, with a remarkably higher expression of the h3 isoform. Alternative termi-
nal axon (ATE) was also investigated and three alternative endings were discovered:
ATE C1, encoding a small portion of exon 32 and exon 33, ATE C2 encoding solely
exon 33 and the full legth terminal exon. Cortical and hippocampal cultures were
prepared from E18.5 mouse brains. From DIV (days in vitro) 1 to DIV 7 isoforms
m4 and m6 were found in all neuronal populations, while from DIV 11 onwards, both
populations expressed also isoforms m1 and m3. Interestingly, motor neurons ex-
pressed the highest variety of isoforms (all of them with the exception of m2) but
lack any significant alternative terminal exon (ATE) splicing. Conversely, ATE C1 and
C2 expression increased from E 13.5 until P9. While ATE C1 expression decreased
until undetectable levels in adult brain, ATE C2 remained constantly present. The
isoform m6/C2 of Kidins220 lacks the KIM, the PDZ and the p75 binding domains.
This shorter isoform co-localized with Kidins220 m6 in the cell body seeming to act
in a dominant-negative fashion by altering the distribution of the full-length protein.
In addition, the isoform m6/C2 was seen to increase the cellular level of TrkA, but
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not of p75, while being incapable of forming the ternary complex with TrkA and p75.
Considering that an increase in Kidins220 full length expression leads to a decrease
in the interaction between TrkA and p75, it was proposed that the fine-tuning of neu-
rotrophin signalling function could be achieved by varying the levels of the different
ATE isoforms. Furthermore, the fast appearance of isoform m1 upon BDNF stimula-
tion in cortical and hippocampal neurons suggests that neurotrophins might influence
Kidins220 function by controlling the expression of its multiple isoforms [39].
Figure 2. Schematic representation of Kidins220 alternatively spliced isoforms [38]. The first
6 isoforms in the upper part are found in mouse tissue (m), while the subsequent three are
found in human tissue (h). At the bottom the splicing isoforms of the carboxy terminal, present
in mouse and human, are represented. On the right, representative PCR products for the
isoforms detected in different adult mouse and human tissues.
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I.V Kidins220 and diseases
I.V.1 Tumour development
Kidins220 protein overexpression has been related to a wide array of cancers (for
review see [40]). The overexpression of Kidins220 was found to facilitate melanoma
formation by suppressing MAPK-mediated stress-induced cell death, and it corre-
lated with reduced patients survival [41].
Kidins220 is also involved in the development of neuroblastoma, a tumour orig-
inating from the neural crest. Kidins220 promotes the survival of neuroblastoma cell
lines by mediating NGF-induced MAPK signalling [42]. Accordingly, the knockdown
of Kidins220 inhibited cell proliferation relenting the G1 phase of the cell cycle [43].
Thus Kidins220 was identified as a possible target for neuroblastoma treatment [44].
Among others, genetic screening described an intragenic break point in the human
KIDINS220 gene related to paediatric high-grade glioma (pHGG) [45].
I.V.2 Alzheimer’s disease
Increased expression of Kidins220 is also associated with the development of Alzheimer’s
disease (AD). AD is characterized by three main pathophysiological characteristics:
extracellular senile plaques containing (Aβ) and intracellular neurofibrillary tangles
(NFT) and hyper-phosphorylated forms of the microtubule-associated protein (MAP)
Tau [46]. The accumulation of Kidins220 in AD was strongly associated with the
accumulation of Tau [47]. Since under physiological conditions Kidins220 is cleaved
by calpain upon neuronal excitotoxicity [20], it was proposed that GSK3-mediated
phosphorylation of Kidins220 in the AD brain would protect it from the cleavage.
Moreover, the quantification of the N-terminal of Kidins220 in the cerebrospinal fluid
of AD patients has been proposed as a biomarker for this disease [48].
I.VI Autism Spectrum Disorder
Autism Spectrum Disorders (ASD) are characterized by two key diagnostic elements
[49]: persistent deficits in social communication (verbal and non-verbal) and social
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interaction across multiple contexts and restricted, repetitive patterns of behaviour,
interests, or activities.
Several studies have related Kidins220 with ASD. Increased expression of
Kidins220 (2.16-fold change) was detected in the blood transcriptome performed on
170 ASD patients and 115 controls. Kidins220 gene was one of the 12 genes with
an average fold change bigger than 1.5. Moreover, alteration of the neurotrophin
signalling pathways is known to be enriched in ASD patients, including the MAPK,
phosphatidylinositol 3-kinase (PI3K) and phospholipase-C (PLC) pathway. These
pathways not only are key to neuronal development and plasticity, learning and mem-
ory but also involve Kidins220 [50]. A genetic screening also related Kidins220 with
ASD, identifying heterozygous deletions of the gene in 3 out of 2446 families [51].
One of the most intriguing aspects regarding the genetics of ASD is the el-
evated number of genes found to be associated with this disorder and the conver-
gence of these genetic risk factors to the same general cluster of symptoms diag-
nosed as ASD. It is believed that this is due to the fact that ASD development de-
pends on convergent downstream mechanisms, which can be affected by diverse
genetic variants. In line with the diversity of risk factors, there is a high heterogene-
ity in the symptomatology of ASD across patients [52]. This is why the research
of this psychiatric disorder involving animal models is focusing on the distinguish-
able subgroups of biological defects known to be present in groups of ASD patients,
known as endophenotypes. As genetic mouse models have emerged in the ASD re-
search, behavioural assays with high relevance to the diagnostic symptoms of autism
have been developed. Considering the types of social deficits in communication and
interaction common in ASD, social behaviour tests have been developed such as
the 3-chamber test [53], social interaction test, social memory test, olfactory ha-
bituation test [54]. Moreover, call categories for responses to social vocalizations,
emitted in response to social cues during reciprocal social interactions, have been
described [55]. For the evaluation of repetitive behaviours and motor stereotypes,
behavioural tests relevant to anxiety, cognitive impairment, hyperactivity and sen-
sory reactivity are used [52], including the open field, elevated plus maze, light-dark,
fear conditioning, Y maze, and Morris water maze tests, as well as the quantification
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of grooming behaviour.
Considering the connection between Kidins220 and ASD, the aforementioned
behavioural parameters have been tested during this project by performing some of
these tests on Kidins220 mutant animals.
I.VII Schizophrenia
Schizophrenia is a dynamically evolving, neurodevelopmental psychiatric disorder
best understood from the psychobiological perspective [56]. Thus, regarding heri-
tability, genetic and epigenetic variants are both crucial risk factors to be considered
when diagnosing this disorder.
Kidins220 has been related to schizophrenia via genetic studies. In 2015
Kranz and colleagues, performed a targeted exome capture of selected neurotrophin
genes, including the Trk receptors, p75, the four main neurotrophins and the Trk in-
teractors Kidins220 and TRIO [57]. Out of 48 cases, 5 were carriers of variations
in the KIDINS220 gene, identified as 2 rare missense polymorphisms and 1 novel
missense mutation. One of the two polymorphisms was located between trans-
membrane (TM) domain 2 and TM3, and the other within the SAM domain. As
previously mentioned, TM domains mediate the interaction between Kidins220 and
multiple receptors, i.e. AMPAR, Trk and p75NTR, while the SAM mediates protein-
protein interactions. The novel missense mutation was located in the poly-proline
stretch, the region that interacts with CrKL leading to sustained MAPK activation
(see Figure 3), and the patient carrying such mutation had severe symptomatology.
It is still not known to what extent these sequence variations affect the physiologi-
cal interactions of Kidins220 and the downstream pathways. Moreover, 50% of the
identified missense coding variants were found in the NGF-TrkA-Kidins220 pathway.
Another study involving 22 schizophrenia patients and 11 controls investigated the
association between the rostralization ratio of N- acetyl-L-aspartate (NAA), which is
a neuronal-specific metabolite that indicates neuronal health and integrity, with rare
missense polymorphisms in PTPRG, SLC39A13, TGM5, NTrk1 and KIDINS220.
This study showed that deficient rostralization is significantly correlated with ver-
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bal decrements and with trait-negative symptoms in schizophrenia. KIDINS220 and
NTrk1 gene variants were located in functional protein domains as the SAM and the
transmembrane domain (see Figure 3) [58]. Another study reported the phenotypes
of subsets of cases with missense coding polymorphisms or novel mutations in four
different genes: PTPRG, SLC39A13, TGM5, KIDINS220, considered genes poten-
tially relevant for psychosis. Remarkably, KIDINS220 missense carriers had lower
mean verbal and full-scale IQ scores, and more severe general psychopathology
symptoms than the other groups. In addition, KIDINS220 variant carriers experi-
enced a severe form of degenerative joint disease. KIDINS220 missense carriers
demonstrated the second slowest processing speed but they scored similarly on all
cognitive measures [59].
A significant overlap of biological pathways between ASD and schizophre-
nia has been established by various studies [60]. Among these common pathways,
the small GTPase family (including subfamilies if the Ras, Rho, Arf, Ran and Rab
GTPases [61]) and MAPK signalling are particularly relevant as they contain many
genes associated to neurodevelopmental disorders, and have been implicated in
synapse plasticity and behaviour [62]. Given the scaffolding function of Kidins220,
we hypothesize that it may represent an element of convergence of signalling path-
ways whose alterations are shared between these two disorders.
I.VIII SINO syndrome
SINO is an acronym for a symptomatology characterized by spastic paraplegia, in-
tellectual disability, nystagmus and obesity, described in three unrelated pediatric
(between 1 and 3 years old) patients carrying de novo nonsense variants in the
KIDINS220 gene [63]. This de novo variants resulted in truncated isoforms of the
Kidins220 protein similar to the ATE C2 splicing variant previously described (see
Figure 4) [38], which is mainly expressed during adulthood. This indicates that
the disruption of the Kidins220 isoforms repertoire possibly caused the neurologi-
cal phenotype found in these patients. As shown in Figure 4, the C-terminal region
of Kidins220 contains the KIM and PDZ domains, which are crucial for protein in-
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Figure 3. Schematic representation of the location of missense variations and mutations in
Kidins220 correlated with schizophrenia [57].
teractions and transport, as explained in paragraph I.I.1.5.KIM domain, I.I.1.6.PDZ
domain. the expression of KIDINS220 is developmentally regulated and differential
splicing occurs in specific tissues as brain, heart and skeletal muscle. Motor neu-
rons exhibit the highest variety of alternative splicing in the middle region, but do
not express ATE splicing. So these patients’ variants resemble isoforms that are
not normally expressed in the developing embryo or present in motor neurons. In-
deed the motor symptoms showed by these patients, i.e. spastic paraplegia and
nystagmus, might be explained by the abnormal expression of the full-length isoform
in motor neurons. The pathophysiology of obesity is instead more probably related
to the involvement of Kidins220 in neurotrophin signalling, since neurotrophins, and
especially BDNF, have been largely related to the control of body weight [64]. Re-
markably, the three patients showed dilated lateral and third brain ventricles, strongly
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reminiscent of the phenotype obtained from Kidins220−/− and cKO mice [31], Sat-
apathy & Almacellas, (Manuscript in preparation: see paragraph I.II.1.Kidins220 KO
line; I.II.3.Kidins220 cKO line). However, not every loss-of-function variant in the last
exon of KIDINS220 causes the phenotype observed in the patients described here,
as three different variants have been identified in 5 healthy individuals [63].
One year after Josifova’s et al. work was published, a frameshift variant
in exon 24 of the KIDINS220 gene was identified by Mero and colleagues. This
variant was the cause of a severe and progressive hydrocephalus, and extensive
limb contractures at gestational week 18, which lead to 4 abortions in a consan-
guineous couple [65]. These fetuses showed very similar phenotypes to those seen
in Kidins220−/− embryos and in the three above-described patients, proving the key
role Kidins220 has in the healthy embryonic development in humans.
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Figure 4. Schematic representation of the de novo variants described in the papers [63,
65]. Above: figure modified from [65]. PTC=premature termination codon, which would be
predicted to elicit nonsense-mediated mRNA decay (NMD). The blue-colored area is predicted
to escape NMD. Bottom: Figure from [63] with the loss of function (LoF) variants described in
the article
I.IX Kidins220 transgenic lines
Two complete knockout (KO) mouse lines of Kidins220 have been developed, which
are both not viable beyond the embryonic period.
I.IX.1 Kidins220 KO mouse line
The full Kidins220 KO mouse line was generated in Dr Schiavo’s laboratory and
first described in 2011 [66]. It was generated by inserting a Kidins220 cDNA-polyA
cassette flanked by two floxP sites in the unique Nrul site of the Kidins220 gene.
Kidins220lox/lox mice were crossed with animals expressing Cre recombinase under
the phosphoglycerate kinase (PGK) promoter to enable Cre activation since em-
bryogenesis [67]. Thus, a mouse line was generated on the C57Bl6/J background, in
which the KIDINS220 gene was ablated from the early embryonic stages. Mice bear-
ing the deletion in the germline were subsequently crossed, originating heterozygous
(Kidins220+/−) animals ubiquitously lacking one Kidins220 allele.
Kidins220+/− animals were viable and fertile. They expressed the same
amount of protein as WT mice and did not show any overt behavioural phenotype.
However, no Kidins220−/− mice were present in the offspring of Het x Het mat-
ings, suggesting that the early homozygous ablation of the KIDINS220 gene was
lethal. Indeed it was seen that up until E15 all embryos were comparable, however
by E18 the Kidins220−/− embryos displayed severe growth defects (Figure 5). The
brains were notably smaller when compared with Kidins220+/+ littermates and their
hearts showed dilated and congested atria as well as disorganized ventricular walls.
These severe heart deformities lead to the identification of the interaction between
Kidins220 and VEGFR, which is key for cardiovascular system development, as pre-
viously described. Kidins220 KO embryos exhibited extensive cell death in both the
central and the peripheral nervous system, in line with the neuronal loss seen in the
fetuses studied in the paper from Mero and colleagues [65]. Moreover, Kidins220−/−
primary neurons displayed an impaired response to BDNF, leading to deficiencies in
cell survival, axonal/dendritic differentiation as well as in the BDNF-induced potenti-
ation of EPSCs [31,66].
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The interaction between Kidins220 and Nav1.2 was studied using cultures of
primary neurons derived from Kidins220 KO embryos. This project led to the charac-
terization of the properties of excitatory and inhibitory neurons lacking Kidins220,
which included hyperexcitability and faster recovery of GABAergic neurons from
trains of stimuli. The KO mouse line has been also used for the study of KO as-
troglia. KO astrocytes show impaired survival/death pathways, specifically reduced
death pathway activation upon ultraviolet radiation and reduced phosphorylation of
MAPK upon BDNF stimulation. Moreover, WT neurons in mixed culture with KO glia
show reduced frequency and firing threshold compared to WT neurons grown with
WT glia (Jaudon et al., manuscript in preparation).
I.IX.2 ARMS heterozigous mouse line
Another line of Kidins220 KO mice was generated in Dr Chao’s laboratory in 2009,
which will be referred to as ARMS KO to avoid confusion with the strain described
in paragraph I.IX.1. This line was generated using the Cre/lox system, by crossing
ARMSlox mice with animals bearing Cre under the actin promoter, which is ubiqui-
tously expressed and active from embryogenesis [68]. The ablation of Kidins220 was
lethal at an early embryonic stage also in this mouse model. However, ARMS+/−
mice were viable and expressed approximately 70% of the physiological amount of
the protein. They displayed decreased dendritic complexity and reduced spine sta-
bility [4], and moreover, ARMS+/− female mice showed reduced spatial memory
formation coupled with cell death in the frontal and entorhinal cortex [69].
I.IX.3 Kidins220 conditional KO (cKO) lines
The biggest challenge in the study of the function of Kidins220 is to discern how this
protein affects the functioning of the adult brain. That is why a cKO line was gener-
ated by crossing Kidins220lox/lox mice with animals expressing Cre under the nestin
promoter, obtaining the nervous system-specific ablation of Kidins220. Nestin- cKO
animals were born alive, however, they died soon after birth due to a neurological im-
pairment leading to impaired suckling behaviour, and were not further analyzed [66].
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Figure 5. Main phenotypes of the Kidins220−/− mouse line. A. Picture of Kidins220+/+
and Kidins220−/− (KO) E18.5 embryos, where the difference in size can be appreciated. B.
Picture of brains from WT and KO mice where the difference in size can be also seen. C.
Heart deficits in Kidins220−/− embryonic heart. Kidins220 KO hearts show congested atria
and higher magnification of the right ventricle wall. [31,66]
Another cKO line was then generated in Dr Cesca’s laboratory, using the same
recombinase system, but this time expressing Cre under the Calmodulin-Kinase II
(CamKII) promoter, which led to the ablation of Kidins220 in the excitatory neurons
of the forebrain, starting from the second postnatal week (Figure 6). The data shown
in this and the following paragraphs were obtained by Dr Satapathy and Dr Jaudon
and represent the basis of the original work described in this thesis. The forebrain-
specific deletion of the protein was validated by western blot analysis (Figure 6 B).
Biochemical analysis performed on WT and cKO brains showed reduced basal lev-
els of phosphorylated TrkB and phosphorylated MAPK (Figure 6 C). This line was
established as a tool for investigating the role of Kidins220 in the development and
functioning of cortico-hippocampal circuits, and in the establishment of higher cogni-
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tive functions and social skills.
Kidins220 cKO (lox/lox; +/CaMKIICre) mice showed comparable development
to their WT (+/+; +/Cre) littermates regarding body weight, size and appearance. A
closer analysis of the brain revealed no cell death in the hippocampus and cortex, no
alterations of the cortical layers and no gross defects of myelination (data not shown).
Dendritic arborization was quantified in the motor and sensory cortex, revealing a
decreased complexity of neurons of the motor cortex in cKO animals (Figure 7).
For a more comprehensive study of the involvement of Kidins220 in the func-
tioning of the adult brain, a behavioural characterization of the CaMKII-Cre Kidins220
cKO mouse model was performed. Before starting with the behavioural testing it
was necessary to validate the general health condition of the cKO animals through
a battery of tests to check the general health, neurological reflexes, home cage be-
haviours and sensory-motor functions. This analysis did not reveal any behavioural
alteration of cKO animals (Figure 8 A). As previously mentioned, a great variety of
behavioural tests have been validated for the study of cognitive functions as memory,
anxiety, risk-taking etc. Because of the engagement of Kidins220 in neurotrophin sig-
nalling and the connection between BDNF and anxiety and memory [70], the mice
were challenged in the open field, Y maze, light-dark and Morris water maze tests.
The open field test is based on the fear of mice to open spaces and it consists
on monitoring the free movement of the mice in a cage for one hour. This test al-
lows quantifying anxiety and hyperactivity. cKO mice showed a burst of hyperactivity
when first introduced in the novel arena, and a constant higher presence in the cen-
tral zone compared to the WT, indicating a low-anxiety phenotype (Figure 8 B). The
Morris water maze tests spatial memory by training the animals to find a platform in
a determinate quadrant of a pool filled with opaque water. After 5 training days, the
ability of animals to remember the position of the platform is evaluated. The spatial
memory is extrapolated by the amount of time the mice spent in the correct quadrant.
cKO females showed impaired spatial memory in the test trial, in line with the results
shown previously with the ARMS+/− mouse line [69] (Figure 8 C). No genotype dif-
ferences were found in the Y maze test, which measures short-term spatial memory,
and in the light-dark test, which evaluates anxiety (not shown).
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Figure 6. CaMKII-driven cKO mouse line validation A. Sagittal brain slices were obtained
from the offspring of CaMKIICre mice crossed with dt-tomatolox/lox animals, at different post-
natal stages. The fluorescence identifies the brain regions where Cre is active. B. (Above)
Protein quantification from western blotting assays of brain lysates of 2-month old WT, Het
and cKO mice. Kidins220 expression is significantly low in the cortex and hippocampus of
Kidins220 cKO mice than in WT animals, while the expression is comparable between the two
genotypes in the cerebellum, as expected (One-way ANOVA, followed by Bonferroni’s post-
hoc test ∗ ∗ p < 0.01; ∗p < 0.05; n=4 animals per genotype). (Below) Protein quantification
of phosphorylated MAPK and TrkB from lysed brain slices ( ∗p < 0.05 Students t-test, n=10
slices per genotype) (Satapathy, Almacellas-Barbanoj et al., manuscript in preparation).
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Figure 7. Sholl analysis of neurons of the motor and sensory cortex of cKO and
WT mice. Representative images (A) and Sholl analysis (B) of neurons from the mo-
tor and sensory cortex of 2-3 months old cKO and WT mice, Brains were stained by the
Golgi-Cox methods, subsequently sliced and imaged. WT (blue) n=6 animals cKO (red)
n=6 animals. The Sholl analysis in the motor neurons showed a significant genotype effect
(F1,10 = 5.248, ∗p < 0.05, RM-ANOVA, Sidak’s multiple comparisons post-hoc test indicates
significantly less intersections in Kidins220 cKO neurons at radius 55-70 µm ) (Satapathy,
Almacellas-Barbanoj et al., manuscript in preparation).
Figure 8. A. A battery of health tests showed the comparable motor and sensory function
and appearance of WT and cKO mice. B. Results of the open field test. Left: total distance
travelled during the 60 min test. The grey rectangle indicates higher locomotor activity by
the cKO mice during the first 5 minutes (Student’s t-test, ∗p < 0.05) Right: time spent in
the central zone. WT (blue) n=21 cKO (red) n=18 cKO mice spend significantly more time in
the centre throughout the entire test with a significant genotype effect (F1,37 = 4.568, ∗p <
0.05, RM-ANOVA). C. Morris water maze test results, depicted as the amount of time spent
in each quadrant of the maze. The south-west quadrant was the one where the platform
was located during the training. WT (blue)= 9 males and 3 females; cKO (red)= 5 males
and 5 females. Males from both genotypes showed the expected performance during the
test with a significant trial effect indicated in the graph (F3,48 = 9.9, ∗ ∗ ∗ ∗ p < 0.001, RM-
ANOVA ). Kidins220 cKO females showed globally poorer performance. Statistical analysis
revealed a signifficant effect, not indicated in the graph for clarity (F3,24 = 28.95, ∗ ∗ ∗ ∗ p <
0.0001, RM-ANOVA) with a significant genotype-trial interaction, indicated in the graph (F3,24 =
3.45, ∗p < 0.05, RM-ANOVA) and significant trial effect indicating different amount of time
in each quadrant, not indicated in the graph for clarity (Satapathy, Almacellas-Barbanoj et
al.,manuscript in preparation).
I.X Aim of the study
A growing amount of literature has identified Kidins220 as a risk factor for impor-
tant psychiatric diseases such as autism spectrum disorders and schizophrenia.
Moreover, mutations in the KIDINS220 gene have been recently identified, which
cause severe neurological phenotypes in human patients. The scaffolding function
of this protein makes it a key convergence factor of crucial signalling pathways, and
a promising element to gain further knowledge on the endophenotypes of these de-
velopmental disorders, and their molecular basis. Given the embryonal/early post-
natal lethality of the full and nervous system-specific Kidins220 knockout animals,
the development of the CaMKII-Cre cKO model represents an extremely useful tool
for discerning the role of Kidins220 in the functioning of the adult brain, and the al-
terations caused by the lack of this protein. On the basis of these considerations,
the aim of this project is to complete the behavioural characterization of the CaMKII-
Cre mouse line using as a guideline the characteristic symptomatology of ASD and
schizophrenia-like mouse models. Importantly, the same characterization is per-
formed on the Kidins220lox/lox ; Kidins220+/+ mice. This is mandatory given the
crucial, and only recently appreciated role of alternatively spliced Kidins220 isoforms
in central nervous system physiology. This approach will allow us to discriminate
and understand the contribution of Kidins220 isoforms (or the lack of thereof) in the




II.I Rationale of behavioural assessment
The main advantage of the cKO model for Kidins220 is its viability, which allowed us
to address the role of Kidins220 in various behavioural paradigms in adult mice. On
the basis of the known roles of Kidins220 described in the literature (see Introduc-
tion), we focused on the following aspects of adult behaviour:
1. Learning and memory (Morris water maze, fear conditioning);
2. Anxiety (open field, elevated plus maze);
3. Social skills (social habituation / dis-habituation, social memory and olfactory
abilities);
4. Sensory-motor gating (pre-pulse inhibition and startle response).
With the exception of the Morris water maze, which was entirely performed
by Dr Satapathy, in this thesis, I describe all the experiments that I contributed to
either partially (anxiety experiments and fear conditioning) or completely (social ex-
periments and sensory gating tests).
All experiments were performed with age-matched, littermate animals. Males
and females were analysed separately in all the experiments. If sex-specific pheno-
types were observed, results from the two genders were shown separately; other-
wise, they were pooled together. The cKO and Kidins220lox/lox animals were obtained
through the mating scheme described in Materials and Methods (see Figure 19), and
the tested animals were of the following genotype:
1. WT (Cre/+; +/+), blue colour in all figures, vs cKO (Cre/+; lox/lox), red colour;




The protocol we followed to assess conditioned fear and contextual memory is shown
in Figure 9 A and detailed in the ’materials and methods’ section. Briefly, the con-
ditioned fear is generated by pairing a footshock with an acoustic cue. 24h later the
fear paired to the context and the cue (associative learning) is tested. Data for the
cKO line are shown in Figure 9 B, while data for the Kidins220lox/lox line are shown
in Figure 18. The strength of the association between the context and cue and the
foot-shock is reflected in the amount of time the mice freeze. During the ’fear con-
ditioning’ (Figure 9 B, C, left) the freezing behaviour increased as more trials (cue
+ foot-shock) were performed, showing a comparable trend in all genotypes. In the
’context ’ phase (Figure 9 B, C, middle), which took place 24 h later, cKO females
froze significantly less than their WT littermates. Importantly, we did not see this
difference between cKO and WT males, in line with the water maze results (see Fig-
ure 8, Introduction). On the other hand, in this phase of the test the performance of
Kidins220lox/lox animals was comparable to Kidins220+/+ for both sexes. In the ’novel
context + cue’phase(Figure 9 B, right), performed 1 h later, cKO mice displayed nor-
mal freezing behaviour in response to the auditory cue, while Kidins220lox/lox mice
froze significantly more than Kidins220+/+ animals. As disussed in section III.III,
WT and Kidins220+/+ animals display different freezing behaviour during the ’novel
context + cue’phase and will be further discussed in the mentioned parahraph.
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Figure 9. Fear Conditioning. A. The three phases of the experiment are shown: the ’fear
conditioning’, the ’context ’ and the ’novel context + cue’ phase. The timeline of the shock and
auditory cues is shown below. In B and C, the amount of time the mice spent freezing during
each phase of the experiment is shown as % freezing time. B. Results for WT (n = 22, blue)
and cKO (n = 17, red) mice. Left: % freezing time for the 3 trials of the ’fear conditioning’
phase. The animals spent significantly more time freezing as the conditioning trial progressed
(trial effect: F6,210 = 57.89, ∗ ∗ ∗ ∗ p < 0.0001 repeated measures (RM) ANOVA), as expected.
Both genotypes show comparable freezing behaviour (genotype effect: F1,35 = 2.81 repeated
measures (RM) ANOVA) Middle: The % freezing time during the ’context ’ phase is shown
separately for males and for females, each circle representing one individual. cKO females
froze significantly less than WT females (∗p < 0.05, Student’s t-test), while no difference was
observed for males. Right: no genotype effect is found in the ’novel context + cue’ trial, where
cKO animals show a conditioned behaviour comparable to WT Indeed, mice of both genotypes
showed an effective and comparable conditioning to the cue (genotype effect: F1,37 = 0.218
repeated measures (RM) ANOVA), as determined by increased freezing behaviour (trial effect:
F2,74 = 62.96, ∗ ∗ ∗ ∗ p < 0.0001 RM-ANOVA). C. Results for Kidins220+/+ (n = 13, cyan) and
Kidins220lox/lox (n = 11, orange) mice. The behaviour of Kidins220lox/lox mice was comparable to
Kidins220+/+ animals in both the ’fear conditioning’ (genotype effect: F1,23 = 0.112 repeated
measures (RM) ANOVA) (Left) and the ’context ’ (Middle) phase. The conditioning protocol
was effective (trial effect: F6,138 = 19.53, ∗∗∗∗p < 0.0001 RM-ANOVA). The time freezing (%)
during the ’context’ trial was comparable between Kidins220lox/lox and Kidins220+/+ in males
and females (p > 0.05; Student’s t-test). Right: mice of both genotypes showed an effective
conditioning to the cue, as determined by increased freezing behaviour (trial effect: F2,42 =
83.66, ∗ ∗ ∗ ∗ p < 0.0001 RM-ANOVA), however Kidins220lox/lox animals showed increased
freezing, when compared to Kidins220+/+ mice (genotype effect: F2,42 = 4.1, ∗p < 0.05 RM-
ANOVA, indicated in the graph; Sidak’s multiple comparisons post-hoc test ∗ ∗ p < 0.01 in
’cue’, ∗ ∗ ∗p < 0.001 in ’post-cue’ not indicated in the graph for clarity). Data are represented
as mean s.e.m. in all panels.
II.I.2 Elevated plus maze
The ’elevated plus maze’ test (Figure 10 A) is a commonly used protocol to test
anxiety levels in rodents. It is based on the principle that open spaces elicit anxiety
on mice. The level of anxiety in the mice is extrapolated by the amount of time the
animals spend in the open arms, whereby a high level of anxiety will be reflected
on a reduced amount of time spent in the open arms. This test was partly done
by Dr Satapathy. cKO mice entered more times to the open arms, compared to
the WT mice (Figure 2 B). However, mice of both genotypes spent a comparable
amount of time in the open arms. Kidins220lox/lox animals instead behaved similar to
Kidins220+/+ mice in terms of both the number of entrances in the open arms, and
time spent there (Figure 10 C).
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Figure 10. Elevated Plus Maze A. Schematic representation of the maze, with 2 open arms
and 2 closed arms. B. Results for WT (n = 17, blue) and cKO (n = 14, red) mice. Bar graphs
(each circle represents one mouse) represent the % entries in the open arms over the total
number of entries, and the % time spent in open arms. cKO mice enter open arms more
frequently than WT animals (∗p < 0.05, Student’s t-test), while the amount of time spent in
the open arms is comparable among the two genotypes. C. Results for Kidins220+/+ (n =
13, cyan) and Kidins220lox/lox (n = 11, orange) mice. The % entries in the open arms and the
% time spent in open arms are comparable between the two genotypes (p > 0.05, Student’s
t-test). Data are represented as mean s.e.m. in all panels.
II.I.3 Open field
The ’open field’ test is based on the same principle as the EPM, i.e. that open spaces
elicit anxiety on mice. The level of anxiety is extrapolated from the amount of time
the mice spend in the centre of the open field, whereby a high level of anxiety will be
reflected in more time spent outside the centre and closer to the external walls Figure
11 3A. As shown in Figure 11 B (data from Dr Sathapathy), cKO mice consistently
spent more time in the central zone of the open field. In contrast, Kidins220lox/lox
mice did not show this trend in behaviour (Figure 11 C). The behaviour of WT and
Kidins220+/+ mice is significantly different and discussed in section III.III.
Figure 11. Open field A. Schematic representation of the open field; the central zone is
highlighted in red. B.Results for WT (n = 21, blue) and cKO (n = 21, red) mice. The amount of
time the mice spent in the central zone during the test is plotted, divided into 5 min bins. cKO
mice spent consistently more time (F1,37 = 4.568; ∗p < 0.05 genotype effect, RM-ANOVA)
than WT in the central zone. C. Results for Kidins220+/+ (n = 14, cyan) and Kidins220lox/lox
(n = 11, orange) mice. In this case, the behaviour is comparable among the two genotypes.




In this test, social interaction and social discrimination are tested (Figure12 A). This
test is based on the increment of interest that social novelty entails in mice. There-
fore, social recognition is extrapolated from the amount of time the test mouse ex-
plores the stimulus mouse. The social interaction behaviour is assessed during the
first 4 trials, where the tested mouse interacts freely with the same mouse (familiar
mouse). The social discrimination capability is tested in trial 5 when the stimulus
mouse is a different one. An increment in the social interaction during trial 5 will
indicate that the tested mouse differentiates the novel mouse from the familiar one.
To evaluate social memory, the time the test mouse spent sniffing the familiar and
the novel mice was evaluated across all trials. As shown in (Figure 12 B), cKO
mice interacted significantly more with the familiar mouse compared to WT animals
over the first four trials (left and middle panels), however, their interest for the novel
mouse during the 5th trial was significantly reduced compared to WT (right panel).
When tested with the same protocol, instead, the behaviour of Kidins220lox/lox mice




Figure 12. Social habituation A. Schematic representation of the test protocol, which con-
sisted of 5 trials of 1 min, separated by inter-trial-intervals (ITI) of 3 min.B. Results for WT
(n = 12, blue) and cKO (n = 16, red) mice. Left: the % time mice were engaged in social
interaction in each trial is reported. Animals from both genotypes showed a significant in-
crease in the social interaction in the 5th trial (trial effect: F4,104 = 18.17, ∗ ∗ ∗ ∗ p < 0.0001
RM-ANOVA, not indicated in the graph). A significant interaction (indicated in the graph) be-
tween genotype and trials indicates different behaviour between cKO and WT (Interaction:
F4,104 = 3.458, ∗p < 0.05 RM-ANOVA. Middle: the average social interaction throughout the
first 4 trials is reported. Each circle corresponds to an individual. cKO mice spent significantly
more time than WT animals interacting with the familiar mouse. (∗p < 0.05, Students t-test).
Right: The difference in social interaction between the 5th and the 4th trial is represented. cKO
mice display less interest for the novel mouse compared to WT animals (∗p < 0.05, Students
t-test).C. Results for Kidins220+/+ (n = 8, cyan) and Kidins220lox/lox (n = 7, orange) mice. Left:
Animals from both genotypes showed a significant increase in the social interaction in the 5th
trial, indicated in the graph (trial effect: F4,52 = 11.74, ∗ ∗ ∗ ∗ p < 0.0001 RM-ANOVA). Middle
and left: the amount of social interaction of Kidins220lox/lox mice is comparable to the one of
Kidins220+/+ animals across all trials. (p > 0.05, Students t-test). Data are represented as
mean s.e.m in all panels.
II.I.5 Social memory
To better define the social memory deficits shown by cKO mice, we performed an ad-
ditional test to assess long-term social memory, which consisted in two 5 min trials of
free social interaction separated by a 1 h inter-trial-interval (ITI) (Figure 13 A). Sur-
prisingly, the performance of WT and cKO mice in this test was comparable (Figure
13 B), in contrast to the results of the social habituation test, previously described.
Of note, we could not use Kidins220+/+ male animals in this test, as they showed a
high level of aggressiveness when put in the same cage with a novel mouse. Thus,
Kidins220lox/lox animals were compared to WT. When the stimulus mouse of the 2nd
trial is the same as the one used in the 1st trial (Figure 13 B, top), a decrease in
social interaction in the second trial is expected, as the tested mouse is expected to
remember the other animal (i.e. long-term social memory) and consequently have
less social interest. WT mice show a tendency towards decreasing the social inter-
action, unlike their cKO littermates. The Kidins220lox/lox mice show the opposite trend
and a bigger inter-subject variability. When the stimulus mouse of the 2nd trial is dif-
ferent from the one used in the 1st trial (Figure 13 B, bottom) the social interaction
is instead expected to be constant.
We also analysed the mating behaviour of our mutant mice (Figure 13 C).
The tested mice were always the males (either WT or cKO). The stimulus females
were WT and in the reproductive stage of the oestrous cycle. In this case, since
Kidins220lox/lox animals did not show any social deficits in the previous tests, we
performed this analysis only on cKO mice. We measured the time male cKO and
WT animals spent sniffing a novel WT female that is introduced in their cage for the
first time and during 5 min. As shown in Figure 13 D, the mating behaviour was
comparable between WT and cKO animals.
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Figure 13. Social memory A. Schematic representation of the test. The mice are left in
the same cage for 5 min, and the ITI Is of 1 h. The second trial is performed with the same
stimulus mouse or a different one.B. Results for WT (n = 23, blue), cKO (n = 22, red) and
Kidins220lox/lox (n=6, orange) mice. Each circle represents an individual.Top: the % time
sniffing the stimulus mouse when it is the same in both trials is shown. The % time spent
sniffing the stimulus mouse is reported for each trial and for each genotype (no statistically
significant effects detected p < 0.05, RM-ANOVA).Bottom: the % time sniffing the stimulus
mouse when it is different between trials is shown (no statistically significant effects detected,
p < 0.05 RM-ANOVA).C.Schematic representation of the male-female interaction test. The
test lasted 5 min.D. Results for WT (n =13, blue) and cKO (n = 9, red) mice. The % time
WT and cKO males spent sniffing a novel WT female is reported. No difference was found




An important component of social behaviour is the ability of animals to discriminate
odours, in particular, social versus non-social odours. To address this point, we per-
formed the olfactory ability test on cKO (Figure 14 A) and Kidins220lox/lox (14 B)
mice. The odours were presented to the mice in cotton swabs dipped in the differ-
ent smells. The time spent by each animal sniffing the cotton swab was evaluated
across all trials. This test allows assessing 3 different parameters: odour differenci-
ation, olfactory habituation to smells and social odour discrimination. The expected
behaviour of a healthy control mouse (see the behaviour of mice from all genotypes
in Figure 14) is an increase in the time sniffing an odour the first time it is presented
(trial 1) and a subsequential decrease on the sniffing time during the following ex-
posure to the same smell (trials 2 & 3). These parameters are determined by the
interest the mouse feels for a novel odour, which is translated to an increment in the
amount of time spent sniffing the cotton swab, while during the subsequent trials the
mouse experiences a reduced interest for odours that are already known. Odour
differentiation and olfactory habituation indicate the correct functioning of the olfac-
tory system. The social odour discrimination is observed in the significant increment
of time sniffing smells coming from other mice (see the behaviour of the WT and
Kidins220+/+ mice in Figure 14), compared to the time spent sniffing neutral smells
(water, strawberry and cinnamon). All the genotypes showed olfactory habituation
and intact olfactory memory to non-neutral smells, thus indicating that the olfactory
system of all mice is not impaired. However, when social odours are presented,
WT and Kidins220+/+ mice showed highly increased sniffing time, as expected for
this type of smell, while interestingly, cKO and Kidins220lox/lox mice spent the same
amount of time investigating the social odours and the neutral ones.
II.I.7 Pre-pulse inhibition and startle response
Sensory-motor gating deficits are correlated to disorders like ASD and schizophre-
nia. These deficits are tested by assessing the inhibition of the acoustic startle when
preceded by a weak stimulus (pre-pulse inhibition, see Figure 15 A), and by as-
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sessing the startle response to acoustic stimuli of different intensities (Figure 15 B).
The inhibition of the startle response elicited by pre-pulses is comparable between
WT and cKO animals across all the tested intensities (Figure 15 A, left). However,
we noticed that in the absence of pre-pulse, cKO mice displayed a trend towards a
reduction of the acoustic startle in response to the most intense stimulus (120 dB).
This genotype effect in sensorimotor response to startle was confirmed by perform-
ing the startle response test, which showed that the startle response to 110 and 120
dB stimuli is significantly lower in cKO mice (Figure 15 B). The same experiments
are presently ongoing for Kidins220+/+ and Kidins220lox/lox mice.
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Figure 14. Olfactory ability The olfactory ability results are expressed as the % time each
mouse spent sniffing the cotton-swab in the presence of different smells, as indicated.A. Re-
sults for WT (n = 19, blue) and cKO (n = 12, red) mice. Mice from both genotypes habituated
equally to each smell and distinguished each new smell from the previous (trial effect:F14,448 =
14.25 ∗ ∗ ∗ ∗p < 0.0001 RM-ANOVA Asterisks are not indicated for clarity). WT mice showed
a significantly higher interest for social odours, unlike cKO mice, so the interaction between
the genotype and the smell is significant (F14,448 = 4.354 ∗ ∗ ∗ ∗p < 0.0001 genotype effect,
RM-ANOVA Sidak’s multiple comparisons post-hoc test between WT and cKO indicated statis-
tically significant differences at all trials within the ’social1’ and ’social2’ odours. Asterisks are
not indicated for clarity). B. Results for Kidins220+/+ (n = 6, cyan) and Kidins220lox/lox (n = 7,
orange) mice. Mice from both genotypes habituated equally to each smell and distinguished
each new smell from the previous (trial effect: F14,154 = 9.201 ∗ ∗ ∗ ∗p < 0.0001 RM-ANOVA
followed by Sidak’s multiple comparisons post hoc test. Asterisks are not indicated for clar-
ity). Kidins220+/+ mice showed significantly more interest for the social smells opposed to
Kidins220lox/lox littermates, so the interaction between the genotype and the smell is significant
(interaction: F14,154 = 5.494 ∗ ∗ ∗ ∗p < 0.0001 RM-ANOVA followed by Sidak’s multiple com-
parisons test ∗ ∗ ∗ ∗ p < 0.0001 for social1 trial-1 for social2. Asterisks are not indicated for
clarity). Data are represented as mean s.e.m. in all panels.
Figure 15. A. Pre-pulse inhibition. Results for WT (n = 14, blue) and cKO (n = 11, red) mice. The % in-
hibition of the startle response induced by pre-pulses of different intensities (74, 78, 82, 85 or 90 dB) is cal-
culated by using the formula: Startle response inhibition=[100− meangofthePPI74or78or82or86or90
startleresponse
]x100,
and it is comparable between the two genotypes. WT and cKO mice show the expected increment of star-
tle response inhibition with increasing pre-pulse intensity (F4,88 = 6.26, ∗ ∗ ∗p < 0.001, RM-ANOVA).
Circles represent the values of single individuals. B. Startle response. Results for WT (n = 14, blue)
and cKO (n = 13, red) mice. The startle response to each auditory stimulus (70, 82, 90, 100, 110 or 120
dB) is evaluated as mean g. The increasing intensity of the startle affected the motor startle response of
both genotypes (trial effect: F5,100 = 87.3 ∗ ∗ ∗ ∗p < 0.0001 RM-ANOVA, asterisks not indicated). Values
are significantly lower in cKO mice compared to their WT littermates for high intensity stimuli, so there
is a significant genotype-trial interaction. (interaction: F5,100 = 24.79, ∗ ∗ ∗ ∗ p < 0.0001, RM-ANOVA
followed by Sidaks multiple comparisons post-hoc test ∗ ∗ p < 0.01 ∗ ∗ ∗ ∗p < 0.0001 at 1000 and 120 dB,
respectively). Data are represented as mean s.e.m. in all panels.
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II.II Role of Kidins220 in adult brain morphology
Previous data by Dr Satapathy had addressed the question of whether, besides its
well-known role in modulating neuronal survival and differentiation during embryo-
genesis, Kidins220 plays a role in the maintenance of neuronal morphology also in
the adult brain. In this work, I completed this analysis and extended it to include the
Kidins220lox/lox mice.
II.II.1 Brain morphology
Kidins220−/− embryos display a marked enlargement of brain ventricles [31]. Here,
we measured brain ventricles in both cKO and Kidins220lox/lox animals, at 2-3 month
of age (Figure 16 A). The volume of the lateral and third ventricles was estimated
from serial brain sections obtained from cKO and WT, Kidins220+/+ and Kidins220lox/lox
littermates. As can be appreciated in the representative images (right) and in the
corresponding quantification (left) cKO mice are characterized by a marked enlarge-
ment of ventricles. A similar trend was observed in the brain of Kidins220lox/lox ani-
mals, which however was not statistically different from Kidins220+/+ mice.
II.II.2 Neuronal morphology
Dendritic branching of cKO mice was previously measured in the motor and sensory
cortex of cKO brains, finding a reduced dendritic arborisation in the motor cortex of
cKO mice (see introduction). Here, this analysis was extended to granule cells of the
dentate gyrus (DG) of the hippocampus of WT and cKO littermates. Golgi-stained
brains were sectioned and single neurons analysed by Sholl analysis. A significant
interaction between the genotype and the number of intersections at each radius
was detected in the DG neurons, indicating more complex and longer denrites in DG
neurons of the cKO mice (Figure 16 B).
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Figure 16. Brain histological analysis A. Left representative brain slices from WT, cKO
and Kidins220lox/lox mice (scale bars, 1 mm); Kidins220+/+ samples were identical to WT (not
shown). Right: hippocampus, third and lateral ventricles volumes are shown. The volume
of the lateral ventricles of cKO mice is significantly larger than that of WT. WT: n= 10; cKO:
n= 11; Kidins220+/+ : n= 5; Kidins220lox/lox : n= 8 (∗ ∗ ∗ ∗ p < 0.0001, Student’s t-test).B.
Left: representative neurons from WT and cKO dentate gyrus, and Right: Sholl analysis
data. A significant interaction between genotype and trial effect was found (F59,1121 = 2.21
RM-ANOVA ∗∗∗∗p < 0.0001, indicated in the graph). 3-10 neurons per animal were analysed,
from WT n= 11, cKO n=10 animals. Data are represented as mean s.e.m. in all panels.
II.III Putative influence of Cre expression on behaviour
The Cre recombinase/lox system is commonly used for the generation of total and
conditional knockout and knock-in mouse models. Animals bearing the Cre trans-
gene are commonly regarded as wild type, however they express an exogenous
protein for a prolonged amount of time in their embryonic and/or adult life, depend-
ing on the promoter used, and the possibility of Cre being a factor of variability per
se should therefore not be disregarded. In the mouse model used in this project,
the Cre enzyme is expressed under the promoter of CaMKII, which is active in fore-
brain excitatory neurons from P14 and throughout the rest of the animal’s life (see
Figure 6, Introduction). To address this issue, here the behavioural results from the
two groups used as controls (Kidins220+/+ and WT) are presented. As shown in
the crossing plan (see materials and methods), the WT littermates of the cKO mice
are Kidins220+/+ ; +/cre, which is the proper control group as cKO animals are
Kidins220lox/lox ; +/Cre. Nevertheless, when the results from WT vs cKO and those
from Kidins220+/+ vs Kidins220lox/lox were put together, substantial differences in
the behaviour of WT and Kidins220+/+ animals were evident in some tests.
In the fear conditioning test, a genotype effect was seen during the ’novel
context + cue ’ trial, where the cued fear is tested. Interestingly, WT (+/Cre) displayed
increased freezing compared to Kidins220+/+ across the baseline, cue, and post-
cue phases (see Figure 17 A, right).
In the open field test, Kidins220+/+ mice spent consistently more time than
WT in the central zone (Figure 17 B), while the performance of the two genotypes
was comparable in the EPM test, in terms of both n. of entries and time spent in the
open arms (Figure 17 C).
Differences between Kidins220+/+ and WT(+/Cre) were also found in the so-
cial habituation / dis-habituation test. Here, Kidins220+/+ showed consistently more
social interaction in all the trials of the test, however, the social memory was pre-
served, as mice of both genotypes displayed increased interest for the novel mouse
(Figure 17 A). The olfactory memory results were also compared and no significant
differences were seen among the two genotypes (Figure 18 B).
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Even though significant differences are found in the behaviour of WT(+/Cre)
compared to Kidins220+/+ , a causal role of Cre in the observed effects is still not
certain. Indeed, a potential effect of altered maternal care should not be discarded.
WT(+/Cre) mice are usually gestated by female mice (+/lox; Cre/Cre) and born into
litters with Het and cKO siblings. The impact that these breeding characteristics may
have on the single animal must be taken into account when comparing WT(+/Cre)
mice with Kidins220+/+ mice, which are gestated by Kidins220+/lox mothers and born
into litters of Kidins220+/lox and Kidins220lox/lox mice.Indeed, the effect of maternal
care in behaviour was observed in [71] among other investigation projects. Thus,
we hypothesize that the observed behavioural variability could be ascribed to spe-
cific cellular effects triggered by prolongued Cre expression, and/or to alterations in
paternal care and in the interaction with siblings of different genotypes, which the
Cre-expressing animals experience throughout their life.
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Figure 17. A. Open field. Results from Kidins220+/+ (n = 12, cyan) and WT(+/Cre)(n =
21, blue) are shown. The amount of time the mice spent in the central zone during the test
is plotted, divided into 5 min bins. Kidins220+/+ mice spent consistently more time in the
central zone than the WT (+/Cre) (genotype effect: F1, 31 = 24.32 ∗ ∗ ∗ ∗p < 0.0001, RM-
ANOVA). B.Elevated plus maze. Results from Kidins220+/+ (n = 13 cyan) and WT(+/Cre)(n
= 17 blue) are shown. The % entries in the open arms and the % time spent in open arms are
comparable between the two genotypes (p > 0.05, Student’s t-test). C. Fear conditioning.
Results from Kidins220+/+ (n = 14, cyan) and WT(+/Cre)( n = 21, blue) are shown. The
amount of time the mice spent freezing during each phase of the experiment is shown as %
freezing time. In the novel context + cue phase, WT(+/Cre) froze more than Kidins220+/+
(genotype effect:F1,31 = 5.619 ∗ p < 0.05, RM-ANOVA). Results are represented as mean
s.e.m in all panels.
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Figure 18. A.Social habituation/ dis-habituation. Results for Kidins220+/+ (n = 8, cyan)
and WT(+/Cre)(n = 12, blue) mice. Left: The % time mice were engaged in social inter-
action in each trial is reported. Kidins220+/+ mice interacted more than the WT(+/Cre)
mice (F1,18 = 6.53 ∗ p < 0.05 genotype effect, RM-ANOVA). Middle: the average social
interaction throughout the first 4 trials is reported. Each circle corresponds to an individual.
Kidins220+/+ mice spent significantly more time than WT animals interacting with the familiar
mouse (∗ ∗ p < 0.01, Mann-Whitney test). Right: The difference in social interaction between
the 5th and the 4th trial is represented. The increment of social interaction between trial 5
and trial 4 is comparable among genotypes (p > 0.05, Mann-Whitney U test). B.Olfactory
ability. Results for Kidins220+/+ (n = 6, cyan) and WT(+/Cre)(n = 22, blue). The olfactory
habituation results are expressed as the % time each mouse spent sniffing the cotton-swab.
The behaviour of cyan the two genotypes is comparable (F1,25 = 1.27, p > 0.05, RM-ANOVA).




A panel of behavioural tests has been performed with the Kidins220 cKO and Kidins220lox/lox
mice. The behavioural characterization was guided by the growing body of literature
identifying Kidins220 as a risk factor for complex psychiatric disorders like ASD and
schizophrenia. The behavioural tests were performed also on the Kidins220lox/lox an-
imals in order to discern which behavioural phenotypes were due to the absence of
Kidins220 in the excitatory neurons of the forebrain, and which ones were due to the
exclusive expression of the Kidins220 full-length isoform (m1), which is characteriz-
ing the Kidins220lox/lox mice. The clear impairment in social olfactory recognition is
the only phenotype shared by the two genotypes. Kidins220 cKO mice are charac-
terized by a social discrimination deficiency and reduced startle response to auditory
stimuli. In addition, they show reduced anxiety in the ’open field’ and ’the elevated
plus maze test’. cKO females have impaired spatial memory, as shown by the re-
sults of the Morris water maze and fear conditioning tests. Kidins220lox/lox mice show
comparable performance to the Kidins220+/+ mice in all these tests (the Morris wa-
ter maze test was not performed with these mice because of technical issues, and
the startle response test is in progress).
III.I.1 Social olfaction and social discrimination impairment and reduced star-
tle response
The ’olfactory ability’ test shows a clear impairment in social odour discrimination in
both cKO and Kidins220lox/lox mice. The expected habituation to each smell across
the trials and the discrimination between each smell, indicate the correct functioning
of the olfactory system in these mice. Therefore the olfactory impairment affects
specifically the recognition of odours from co-specific animals. This is indicative of
the relevance of Kidins220 isoforms for the correct codification of social odours in
adult mice. As previously explained (see Introduction), the difference between cKO
and Kidins220lox/lox mice is the absence of Kidins220 in the excitatory neurons of the
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forebrain of the cKO mice. What they have in common is the exclusive expression of
a full-length isoform of Kidins220 (m1, FL) everywhere else. The recently described
SINO syndrome in humans proves the value of the correct expression of Kidins220
splicing isoforms, and the severe consequences that their absence entails [63,65]. It
is probable that the different protein-interaction domains present in each Kidins220
isoform is the reason for their specific location and differential expression during
development. Moreover, neurotrophins appear to have a key role on the timing of
this expression [38].
Among the multiple and diverse signalling pathways Kidins220 is involved in,
it was found to interact with sodium channels. Sodium channels are fundamental
players in neuronal communications. They are multimeric complexes of α and β
subunits that exist in several isoforms and their functional characteristics depend
on which subunits compose each channel. Sodium channels as Nav 1.2 and Nav
1.9 are known to be modulated by BDNF [36]. In fact, Kidins220−/− hippocampal
GABAergic neurons display a higher Na+ conductance [36]. In addition, MEA (Multi
Electrode Arrays) recordings of mouse hippocampal cultures indicated impairment in
the polysynaptic and reverberant propagation of excitation in neuronal networks lack-
ing Kidins220 [36]. During this same work, the direct interaction between Kidins220
and the sodium channel Nav1.2 was observed. Nav1.2 channels are subject to dy-
namic regulation by tyrosine phosphorylation/dephosphorylation events upon TrkB
activation, which leads to increase their fast inactivation by Fyn kinase [72]. This
points towards the role of Kidins220 as an intermediary between Trk neurotrophin
receptors and the downstream modulation of sodium channels activity [36]. There-
fore, Kidins220 is probably located upstream from Na+ in this signalling pathway.
Olfaction is a major modality through which animals may detect and identify
conspecifics. The olfactory system is key for mice survival and social behaviour. For
example, scent marking and counter-marking of the scent marks of other males are
important components of dominance advertisement among male house mice, and
strongly influence their aggressive interactions. In addition, females respond to male
urinary pheromones in a variety of ways that enhance their reproductive success,
including early induction of puberty and the capacity of activating the same neuroen-
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docrine mechanisms resulting in loss of pregnancy [73]. The detection of odourants
is registered by two distinct chemosensory systems originating in the nose: the main
olfactory system (MOS) with receptors that encode signals to the main olfactory bulbs
(MOB), and the vomeronasal organ (VNO) composed of axons connecting with the
accessory olfactory bulb (AOB), an anatomically independent region in the posterior
part of the olfactory bulb. The AOB and MOB give rise to separate pathways that
terminate in both separate and overlapping areas of the basal telencephalon. From
the amygdala, vomeronasal pathways project to the medial preoptic area and the
ventromedial nucleus of the hypothalamus. Selective disruption of the MOB, leaving
the accessory system functionally intact, has only a minor effect on aggression, but
completely disrupts mating behaviour in male mice. Removal of the VNO alone does
not affect mating behaviour, but markedly reduces scent marking responses and ag-
gressive behaviour to other male mice [74]. Nav channel isoforms are distributed in
specific locations of the olfactory system, being Nav1.7 the most abundant subtype
not only in the MOS but also in the VNO, and Nav1.2 and Nav1.6 specifically located
in sensory neuron subpopulations of the VNO [75].
The Kidins220 cKO mice show no impairment in mating behaviour but fail to
distinguish between social and non-social odours, as the Kidins220lox/lox mice do. In-
terestingly, this phenotype is in line with the effects caused by VNO ablation in mice.
Nav1.2 channels are expressed in the soma of the vomeronasal sensory neurons
of the VNO basal layer [75]. Therefore it is possible that the absence of m6, one of
the two brain-specific Kidins220 isoforms [38], leads to an inhibitory/excitatory unbal-
ance due to the impaired regulation of sodium channels upon neurotrophic signalling,
eliciting a defective encoding of social odours by the VNO. The preliminary results
of the DHF treatment on the ’olfactory ability test’, where social odour discrimination
seems to be rescued by the treatment, point towards the involvement of BDNF. It
has been reported that BDNF and TrkB deficiencies non-specifically affect the dis-
crimination of all odours [76]. Therefore, the aforementioned role of Kidins220 as
a modulator of sodium channels appears to be of great relevance for social odours
discrimination, and interestingly, this seems to by linked to BDNF signalling. The
rescue experiment results also reveal an interesting trend of differential effects of
48
7,8-Dihydroxyflavone (DHF) on males and females (see Figure 19 A, B in Future
perspectives section IV.I). Social odour discrimination in females seems to be more
effectively rescued than in males. Indeed it has been previously reported that female
olfactory system is generally more effective than the male one, and the molecular ba-
sis of these sensory differences could be partly related to differences in the endocrine
status [77]. odourant presentation in females elicits olfactory sensory neurons (OSN)
input into a broader range of olfactory bulb glomeruli and this input occurs earlier in
the odour presentation compared to males [77]. Moreover, sex hormones modulate
BDNF signalling in different ways in males and females. The BDNF gene contains
an estrogen-response element, which establishes a positive correlation between es-
trogen and BDNF expression [78]. Conversely, testosterone has a decreasing effect
on BDNF-TrkB signalling during adolescence [79]. Given these sex-specific char-
acteristics, the action of DHF is probably more effective in the females VNO, which
would favour plasticity upon BDNF-signalling increment. In addition, given that the
lack of Kidins220 isoforms is likely to impair BDNF signalling, the effect of testos-
terone on this neurotrophin and the TrkB receptor during adolescence might entail
VNO circuit defects not modifiable by DHF treatment. Social recognition is impaired
in Kidins220 cKO mice, in line with the social odour discrimination impairment shown
by this genotype. The fact that Kidins220lox/lox mice do not show the same impair-
ment indicates that this phenotype is caused by the absence of Kidins220, rather
than by an unbalance in its isoform expression. Moreover there were no significant
differences between Kidins220lox/lox males and females in neither of the two tests.
Kidins220lox/lox mice showed comparable social recognition to their Kidins220+/+ lit-
termates, underlying the relevance of the expression of Kidins220 in the forebrain
for social behaviour. Therefore differences in ’olfactory ability test’ and ’social habit-
uation test’ indicate involvement of different, yet some overlapping, brain circuits. In
the work published by Ferguson and colleagues [80], mice lacking the oxytocin gene
showed social recognition impairment when tested in the same social habituation
paradigm as the one used during this project, as the vasopressin receptor V1a KO
mice did [81]. A key role of oxytocin receptors in the aDG-CA2/CA3 hippocampal
axis was later identified by Raam and coleagues [82]. Additionally, BDNF and its
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receptors are highly expressed in the paraventricular nucleus (PVN), were neurons
synthetizing oxytocin are located. In fact a disruption of BDNF signalling may lead
to increased inhibition onto oxytocinergic neurons that could alter the timing or levels
of oxytocin release, with an appreciable impact on social behaviours [78]. Moreover,
the reduced startle response shown by cKO mice is also in line with the putative
interaction between oxytocin, BDNF and Kidins220; indeed, oxytocin KO mice have
reduced startle response [80].
The involvement of the hippocampal DG in the social recognition circuitry pro-
vides the connection between the differential dendrite ramification found by Sholl
analysis in the brain area and the social recognition impairment of Kidins220 cKO
mice. Oxytocin has been largely proposed as an important element for the under-
standing of complex disorders as ASD and schizophrenia [83]. In parallel, the de-
creased BDNF expression induced by testosterone in adolescent males has been
proposed as a risk factor for the development of chronic schizophrenia [79]. The
marked social impairments in ASD and schizophrenia and the crucial role of oxy-
tocin in social cognition indicate that oxytocin is a promising treatment target for
these disorders. Kidins220 interaction with BDNF, which in turn is a regulator of oxy-
tocin signalling [78], makes Kidins220 one genetic risk factor to take into account in
order to diagnose and treat these complex disorders.
III.I.2 Contextual memory impairment in cKO females
The results obtained in the Morris water maze and in context trial of the fear con-
ditioning test reveal impaired spatial memory in Kidins220 cKO females. Our data
are in line with the published literature, as spatial memory deficits were also identi-
fied in ARMS+/− females, which showed a reduced performance in the training trial
of the Morris water maze [69]. This sex-specific impairment may point towards es-
trogen functions in learning and memory. During the last decades, the involvement
of 17-estradiol (E2) in the regulation of learning and memory in male and female
rodents has been established. Ovariectomy itself impairs some forms of memory in-
cluding spatial reference memory in the water maze, and systemic E2 given acutely
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or chronically improves spatial working memory. Interestingly, the primary endoge-
nous source of E2 for hippocampal neurons in both males and females is probably
the neuronal and glial hippocampal population itself. Indeed, systemic injection of E2
synthesis inhibitor letrozol is associated with impaired long-term potentiation (LTP)
and transient dephosphorization of cofilin in male and female rats, although these
deficits are more striking in females. Not only LTP becomes deficient, but also spine
density and variety decreases more in females than in males. In addition, E2 acts
on learning and memory by activating the ERK signalling pathway [84]. It will be
interesting to address the question of whether such deficiency is exclusively linked to
BDNF signalling, or whether estrogen signalling is also impaired, and if so, whether
this is more relevant in females.
III.I.3 Reduced-anxiety behaviour
Kidins220 cKO mice show reduced anxiety-like behaviour in the open field and the
elevated plus maze tests in the absence of hyper locomotion. This behavioural char-
acteristic has been described in diverse mouse models as the CamKII-driven Cre
BDNF cKO [85], the CamKIV KO [86], and the vasopressin V1a (V1aR) receptor KO
mice [81]. On the other hand, mouse models expressing the BDNF Val66Met allele in
homozygosity display enhanced anxiety-like behaviour due to stress-induced BDNF
reduction in the hippocampus [70]. In case of human studies, also a similar trend was
observed in case of the Val66Met SNP [87]. Various mouse models characterized
by reduced anxiety-like behaviour have been developed, however the mechanism
underlying this phenotype has been challenging to explain. For instance, previous
pharmacological investigations into the role of the V1aR in anxiety have yielded a
contradictory and inconsistent collection of data [81]. Furthermore, CaMKIV when lo-
cated in the nucleus, phosphorylates cAMP response element binding (CREB). The
reduced anxiety-like behaviour in CaMKIV KO mice contradicts the reported increase
in anxiety-like behaviour in CREB-deficient mice, while CREM (CREB-related tran-
scription factor) mutant mice were hyperactive in the open field but displayed reduced
anxiety in the elevated plus maze. Moreover CaMKIV mice had a down-regulation
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of the oxytocin and the vasopressin genes. The decreased vasopressin expression
is in line with the phenotype observed in V1aR phenotype, while the decreased ex-
pression of oxytocin counteracts the accumulating evidence suggesting that oxytocin
possesses anxiolytic properties. The neuronal circuitry involved in anxiety is known
to involve the amygdala and hypothalamic areas, but as the data exposed indicates,
the specific signalling pathways involved in the regulation of anxiety-like behaviour
is unknown. Regarding that CamKIV and BDNF are involved in the regulation of
MAPK signalling pathway, the phenotype the Kidins220 cKO mice display is proba-
bly caused by a defective activation this pathway. Nonetheless further studies need
to be conducted in order to clarify the specific involvement of Kidins220 in this anxi-
olytic effect.
III.II Brain morphology: hydrocephalus
The brain morphology analysis of the Kidins220 cKO mice revealed a notable en-
largement of the lateral and the third ventricles in the absence of cell death, dis-
ruption of cortical layers and alteration of hippocampal volume. Intriguingly, cKO
mice are physically identical to WT, so they do not display the typical cranial defor-
mities that are usually associated with hydrocephalus. Moreover, the hippocampal
and overall gross brain volume are comparable between WT and cKO mice. When
the enlargement of ventricles begins during childhood, the cranial deformities occur,
given that the complete cranial suture closure takes place between P7 and P12 [88].
In contrast, when the ventricle dilatation occurs in young adulthood or after, no de-
formities in head shape are observed. It is probable that the absence of cranial
deformities in cKO is due to the timing of the Kidins220 ablation (P14). Although
there is no statistical difference in the brain ventricle volume of the Kidins220lox/lox
mice compared to the Kidins220+/+ mice, a tendency towards enlargement and a
high variability across individuals is visible. Therefore the m6 isoform is possibly
relevant in the maintenance of brain ventricles as well. This phenotype is strongly
conserved across species, as the SINO syndrome in humans, which is caused by
the expression of loss-of-function variants of Kidins220, has hydrocephalus as one
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of its main symptoms. It is in fact clear the crucial role Kidins220 has on the devel-
opment or maintenance of healthy-size brain ventricles, but the mechanism involved
is yet to be unraveled. Indeed, the fact that these pathological manifestations of the
SINO syndrome may be generated through a loss-of-function mechanism, whereby
the truncated variant cannot fulfill the roles of the full-length protein. However, the
truncated variants identified in the three patients are similar to the Kidins220 isoform
expressed during adulthood. This points towards a gain-of-function effect, as these
isoforms are expressed at a developmental stage when they are usually not present.
Altogether, the pathophysiology of the SINO syndrome is presently unknown and can
be only speculated upon, and it will be the focus of our future investigations.
III.III WT(+/Cre) mice phenotype differes from Kidins220+/+ mice
The data on Cre expressing animals reveal an impact of Cre on some behavioural
tests. WT(+/Cre) mice are characterized by increased anxiety-like phenotype in the
open field and reduced freezing behaviour during the novel context + cue trial of fear
conditioning test, in absence of a defective auditory fear conditioning. In addition
WT (+/Cre) display less social interaction in the ’social habituation test’ in absence
of impaired social discrimination. Albeit we did not address this issue, we believe
also some morphological properties of brain neurons, such as dendritic arboriza-
tion or spine/synapse formation, may be affected by Cre expression. In addition,
the impact of Cre and its expression levels are bound to be very different depend-
ing on the promoter controlling its expression, and on the genetic background of
the colony. The mechanisms underlying the observed alterations were not further
investigated since it would go beyond the scope of this project. However, this indi-
cates that Cre-expressing mice should not be considered as wild type, but always be
taken as control when a conditional knockout colony is under study. Moreover, the
fact that WT(+/Cre) and Kidins220+/+ mice are born in different litters should not be
ignored. The importance of maternal care and sibling interaction is known to be cru-
cial for behaviour and cognition in adult mice (and humans). As a consequence, Cre
expressing mice are the most appropriate controls for cKO because of the putative
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effects of Cre in the mice physiology, but also because of the environmental effects
during embryonic stage and childhood. That being said, Cre expressing mice are





As described in the introduction, Kidins220 interacts with all other neurotrophin re-
ceptors, and in the brain, this is particularly relevant for TrkB. It is already known
that brain slices from cKO mice have lower basal levels of phosphorylated MAPK
and phosphorylated TrkB receptor, indicating lower basal levels of activation of the
MAPK pathway (Figure 6, Introduction). With the objective of gaining further in-
sights on the molecular pathways involved in the behavioural phenotype seen in the
cKO mice, a phenotype rescue experiment has been initiated. The possible involve-
ment of BDNF signalling in the behavioural defects is being investigated by treating
the mice with the BDNF-mimetic drug DHF. DHF is known to cross the blood-brain
barrier upon oral ingestion and induce BDNF/TrkB signalling [89]. DHF is part of a
group of small molecules widely used for the TrkB stimulation in vivo. However, the
exact mechanism by which DHF elicits this effect is presently not known and object of
debate since many of those molecules have failed to show TrkB phosphorylation and
ERK pathway activation in vitro. Nevertheless, a considerable amount of literature
shows DHF-induced activation of TrkB signalling in vivo. One current interpretation
of the published data is that it is not the DHF molecule per se that acts as a BDNF-
mimetic drug, but rather the metabolites originated upon DHF digestion [90]. The
treatment protocol was done following the indications described by Parrini and col-
leagues [91] (details are provided in the Materials and Methods section) diluting
DHF in the mice drinking water. The solution intake of both vehicle and treatment
groups were monitored, as well as the weight of the animals. All the treated mice
were housed in couples.
We considered three experimental groups: (i) WT and (ii) cKO treated with
vehicle solution (controls), and (iii) cKO treated with DHF solution. The inclusion of a
4th group was considered, i.e. WT treated with DHF, however, it is reported that DHF
failed to induce significant changes in TrkB signalling in wild type animals [91], there-
fore this group has not been included in the experimental procedure. The behavioural
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tests performed on the treated mice were the ones where an impaired phenotype
was previously observed in cKO, i.e. fear conditioning, open field, elevated plus
maze, social habituation / dis-habituation, and olfactory memory. The experiments
are still in progress and only a limited number of animals have been tested, therefore
no statistical analysis has been performed yet. Amongst those tests, the results of
the olfactory habituation are the most promising, and are shown in Figure 19 A. The
behaviour of cKO-DHF animals, in fact, was more comparable to the WT-vehicle than
to the cKO-vehicle mice, being the behaviour of the two vehicle groups comparable
to the previously obtained results. In addition, females cKO-DHF seemed to be more
affected by the treatment than the males, as their behaviour was indistinguishable
from that of the WT-vehicle mice (Figure 19 B). Consequently, there probably is a
partial rescue of the phenotype by elevating TrkB signalling in vivo.
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Figure 19. A. Olfactory ability. Results for WT-vehicle (n = 9, blue), cKO-vehicle (n = 2, red)
and cKO-DHF (n = 7, magenta, full circles) animals are shown. The olfactory habituation re-
sults are expressed as the % time each mouse spent sniffing the cotton-swab in the presence
of different smells, as indicated. B. Results for WT-vehicle (n = 9, blue), cKO-DHF males (n
= 4, dark magenta) and cKO-DHF females (n = 3, pink) mice. The results are expressed as
means.e.m. in both panels.
IV.II Social behaviour impairment
cKO mice have impairment in social odour discrimination and conspecific discrimi-
nation, which is a phenotype observed in oxytocin-deficient mice. In addition, oxy-
tocin has lately been a widely chosen target for the study of social deficits in ASD
and schizophrenia. Given the scaffolding function of Kidins220, it is probable that
it serves as a converging element between BDNF and oxytocin signalling pathways,
leading to the observed phenotypes in Kidins220 cKO and Kidins220lox/lox mice. Oxy-
tocin expression quantification has proven to be challenging, so its involvement in
Kidins220 role in social behaviour will be determined by gene expression of oxytocin
and its receptors. Not only oxytocin has been strongly involved in social behaviour,
when it comes to determining relevant brain areas, but CA2 has also been related
to social memory [92]. The planned assessment of gene expression is intended
to be complemented by electrophysiological studies of CA2 connectivity and excita-
tory/inhibitory balance in Kidins220 cKO mice. Following this research path, it would
be useful to observe the excitatory/inhibitory balance of the VNO and its connectivity
with cortical encoding areas as the piriform cortex. Given the involvement of BDNF
in the processing of social odour encoding and the hidrocephalus detected in the
cKO, the rostral migratory stream could be involved in this phenotype. The subven-
tricular zone (SVZ) is a known source of neuronal progenitors in adult rodents that
provides the olfactory bulb with new neurons. BDNF is a growth factor with key in-
volvement, shared with Kidins220, in neuronal progenitors migration maturation [93],
and Kidins220 may be part of this signalling system. Moreover, since the SVZ lays
immediately adjacent to the ventricles, the presence of hydrocephalus may cause
physical damage to the cells in that zone. We plan to perform a series of histochem-
ical and biochemical studies in order to assess the possible relation between BDNF
signalling and the rostral migratory stream, ventricle enlargement and the impaired
social odour recognition in cKO mice.
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IV.III Sexual dimorphism
Different phenotypes in males and females in contextual memory and social olfactory
discrimination rescue indicates a putative distinctive function of Kidins220, related to
estrogenic and androgenic signalling. The relevant involvement of sex hormones in
learning and memory and the endogenous synthesis if these compounds in brain
areas as the hippocampus indicate a research line to be explored. ASD have a 5:1
ratio of incidence on boys:girls in humans (autism.org.uk) and schizophrenia onsets
in an earlier age in men [94]. Therefore sex dimorphism is a relevant issue to study
more importantly when investigating the role of a documented genetic risk factor for
these psychiatric disorders as Kidins220. That is why estrogen signalling paired to
downstream BDNF and Kidins220 activation will be assessed by quantifying protein
expression and phosphorylation of downstream BDNF effectors. In addition, gene
expression will be determined for DHF-treated mice.
IV.IV Neuronal morphology
The hypothesised defective BDNF signalling in Kidins220 cKO mice could be re-
sponsible for the observed decreasing dendritic arborisation in the motor cortex and
the differential pattern in dendritic arborisation in the dentate gyrus of the hippocam-
pus. Dendritic spine quantification and morphological analysis will be done in cKO
and DHF treated cKO not only in the motor cortex and the dentate gyrus but also
in the other affected areas as CA2-CA3 areas of the hippocampus and the VNO.
Understanding the molecular and physiological role of Kidins220 in the adult cortico-
hippocampal circuits will provide a potential research path towards a deeper un-
derstanding of symptomatology in psychiatric disorders as ASD and schizophrenia.
This would contribute to earlier diagnosis and more importantly intervention upon the
onset of these disorders.
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V Materials and methods
V.I Animals
In this study, three different mouse lines were used. The Kidins220lox colony and the
CaMKIICre colonies were used to generate the Kidins220 cKO mice. The Kidins220lox
colony was obtained from Dr G. Shiavo (UCL London, UK) and the CaMKIICre
mouse line was bought from Jackson Laboratories (Maine, USA) [#B6.Cg-Tg(Camk2a-
cre)T29-1Stl/J]. All the animal colonies used were on the C57BL/6 background. All
procedures were approved by the Italian Ministry of Health (permit n◦ 254/2015-PR
and permit n◦ 474/2018-PR) and strictly adhere to the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National Institutes of Health.
V.I.1 Crossing plan
In order to analyze the role of Kidins220 in the adult mouse brain, a new condi-
tional knockout mouse line was generated by crossing the Kidins220-lox animals
with transgenic mice that express Cre recombinase under the control of the Calmod-
ulin dependent Protein Kinase II (CaMKII) promoter. This promoter was selected
because it drives the expression of Cre only in the excitatory forebrain starting from
the second postnatal week, thus circumventing developmental defects in the ner-
vous and cardiovascular systems. This line was established as an essential tool to
investigate any abnormalities arising in the adult brain due to the lack of Kidins220,
as well as to understand the role of Kidins220 in the formation and maintenance of
the cortico-hippocampal circuits. A 4- step crossing plan was designed to obtain the
cKO animals, as shown in Figure 20.
V.I.2 Genotyping of animals
All animals were individually genotyped with the polymerase-chain reaction (PCR)
technique for the floxed allele, for the Cre allele and for the tissue-specific activa-
tion of Cre. Genomic DNA was isolated from tail or ear snips of young mouse pups
for determining their genotype. This tissue was lysed rapidly by incubating it in 50
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Figure 20. Crossing plan. Kidins220-lox animals are in black, CaMKIICre animals in white,
all the intermediate genotypes are in grey, cKO animals are depicted in pink. The expected
percentage of pups of each genotype is indicated.
mM sodium hydroxide (NaOH) at 98◦C for 50 min. Kidins220lox/lox and CaMKIICre
genotyping PCRs were performed using the GoTaq Green PCR Master Mix (M712,
Promega). It is a ready-to-use solution that facilitates the direct loading of the PCR
products onto agarose gels. It contains Taq DNA Polymerase, coloured dyes, MgCl2
and dNTPs. The genomic DNA amplified by the PCRs was run on a 2% agarose
gel (prepared by dissolving 2% agarose in Tris Acetate-EDTA (TAE) Buffer (Sigma-
Aldrich) and SyverSafe at a final concentration of 0.1 µg/mL). The PCR samples
were loaded directly onto the agarose gel and electrophoresed at 80 V in TAE Buffer.
5 ng of the genomic DNA were used for performing a quantitative PCR using an
ABI 7500 and the TaqManR Universal PCR Master Mix, no AmpEraseR UNG (Ther-
moFisher Scientific). A fluorophore-quencher combination (as recommended by the
Jackson Laboratory) was used to determine if the Cre transgene was expressed in
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Table 1. List of primers










Internal Positive Control Fw CTAGGCCACAGAATTGAAAGATCT






Internal Positive Control Fw CACGTGGGCTCCAGCATT




The mice tested were 3-5 months old. The animals were housed with minimum 2
and maximum 6 mice per cage, in a climate-controlled animal facility (22◦C±2◦C)
and maintained in a 12 h light/dark cycle. Even though specifically cKO and WT
and Kidins220+/+ and Kidins220lox/lox mice were tested, the heterozygous for both
genotypes were kept in the cages to avoid changes in housing conditions. Food and
water were available ad libitum. 1 h habituation in a third room was mandatory before
performing all tests. Males and females were tested separately in all tests, cleaning
the apparatus with 70% ethanol between different animals as well as different trials.
The animals were handled by the experimenter the week prior to the tests, during 3-5
days (the mice were handled until fear reactions as jumping, defecating or urinating
during handling were extinguished) 5 minutes per animal. Experimenters were blind
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to the mouse genotype during testing and behavioural scoring.
V.II.1 Fear Conditioning
The Any-maze software was used for recording and storing the videos. The experi-
menter scored the freezing behaviour manually.
Conditioning phase: A 40 cm x 40 cm closed chamber with transparent walls
and an electrical grid as a floor is used for the test where the animal is situated.
The animals were tested for 510s. During this session, the cue (i.e. the sound
of 75 dB of volume and 4 kHz of frequency) was followed by the aversive stimu-
lus (i.e. an electrical foot shock of 0.7 mA of intensity), which constituted a trial
of 30 s followed by an inter-trial interval (ITI) of 90 s. The animals were con-
ditioned with 3 consecutive trials after 2min of habituation to the conditioning
chamber using theTSE Multiconditioning System, FCS v9.02 or Shuttle 4.07.
Context phase: 24 h later the animals were tested in the conditioning chamber
for 5 min without the tone or foot shock. The environmental conditions were
kept identical to the training session.
Novel context phase: 1 h post context testing, the animals were tested in a
novel environment for 6 min. The animals were in 40cm x 40cm chamber of
black opaque walls, with the grid floor covered with a grey plastic cover and
a filter paper embedded in 20µl of apricot essential oil. The animals were
exposed to the same cue played during the conditioning phase, during 2 min
after a 2 min habituation to the novel context. After the cue, the animals were
kept 2 min in the novel chamber.
V.II.2 Open field
The basic locomotor activity was tested in the open field test by placing each animal
in a large square empty open arena (45 cm X 45 cm X 45 cm) surrounded by non-
transparent sides for 30-60 min under red light. The mice were situated in the centre
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of the maze at the beginning of the test. An overhead camera recorded the animals
and the video was stored, tracked and analysed by the Stoelting ANY-maze software
(U.S.A.). Stoelting ANY-maze software (U.S.A.) calculated the total distance covered
and average speed. A square 20 cm X 20 cm zone was determined in the centre of
the arena (marked as the central zone). The same software also calculated the time
spent by each animal in this zone.
V.II.3 Elevated Plus maze
The elevated plus maze is a plus shaped maze with four equal sized arms (30 cm
X 15 cm), two of which lack sides, while the other two are walled (15 cm high). The
maze is elevated by 70 cm from the ground level. The test was performed under
red light and during the experiment the experimenter was present in the room. The
mouse began the test being situated in the middle of the cross. An overhead camera
recorded the test. The Stoelting ANY-maze software was used to score the video
and calculate the number of entrances into each arm and the time spent in each
arm.
V.II.4 Social habituation
The social habituation test was performed as similarly reported previously [95] in
a transparent plastic cage with filter lid and ∼ 1cm of bedding. The experiment
consisted of 5 trials that lasted 5 min with inter-trial-intervals of 2 min. During the 4
first trials the test mouse (the animal being tested) was faced with a stimulus mouse
(which was always WT or Kidins220+/+) and they were free to interact. During the
5th trial the stimulus mouse was a different one (still with the same genotype as the
anterior stimulus mouse). A camera situated beside the cage recorded the test. The
social habituation was assessed by manually determining the social interaction (%
time the test mouse spent sniffing the stimulus mouse).
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V.II.5 Social memory
The social memory test was performed in a transparent cage with filter lid and ∼1 cm
of bedding. The test mouse (the mouse monitored for assessing its social behaviour)
was placed in the cage 1 h before the test for habituation. After that, the stimulus
mouse was introduced to the cage and the animals were free to interact during 5min.
After that, the stimulus mouse was extracted from the cage and the test mouse
remained in the testing cage during the 1 h inter-trial-interval. Then, the stimulus
mouse for the 2nd trial was introduced to the cage for 5 min of social interaction.
When the stimulus mouse on the second trial was different from the first stimulus
mouse, it was selected from a different cage. Some of the social interaction trials
derived in violent interactions. These trials were not accounted for in the results.
Most of the test animals were tested in the two modalities of the experiment (the
second trial with the same stimulus mouse or with a different one). When testing the
same test mouse, the two parts of the experiment where performed 24 hours apart.
V.II.6 Olfactory memory
The olfactory habituation test was performed following the protocol described in the
paper from Yang, M. and Crawley, N. in 2009 [96]. The non-social odours presented
to the mice were cinnamon and strawberry essential oils. The cotton tip was dipped
during 2 s and then let dry during 5 s. The test was performed in 210E Tecniplast
cage (35.5 x 23.5 x 19 cm) lightly illuminated (5±1 lux). The experimenter was in the
room throughout the entire test registering with a digital timer the sniffing behaviour
during each 2 min trial. Social odour stimuli were acquired by swiping the cage
bottom from mice matched in genotype and gender to the tested mice.
V.II.7 Pre-pulse inhibition and acoustic startle response
Acoustic startle response and prepulse inhibition (PPI) were measured using four
TSE Multiconditioning System, FCS v9.02 or Shuttle 4.07, following the protocol
reported in [97]. Startle and PPI experiment test sessions began by placing the
mouse in the metallic chamber (5cm x 5cm x 5cm). During the startle response test
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each subject received 36 trials over a 9 min session. Each stimulus was 40 ms and
presented four times at pseudorandom order and the ITI was 10-20 ms. The TSE
System software registered the startle amplitude, the mean amplitude was used as
dependent variable. During the PPI test the trial types were presented randomly
within each block. The ITI were 10-20 s Prepulse tones were at 20 ms and each trial
was a 40 ms, 120 dB sound.
V.III Histology experiments
V.III.1 Brain ventricle volume measurements
Brain extraction: The mice were anesthetised with a lethal dose of isofluo-
rane and perfused transcardially with approximately 15±5 ml of a 4% solution
of paraformaldheide (PFA) in phosphate-buffered saline (PBS) 1x. Once the
tissue fixation was assessed by the level of stiffening of the tail and jaw of the
animal, the brain was extracted. All the brains were incubated at 4◦C in 4%
PFA during 24 h post-extraction and then transferred to a 20% sucrose solu-
tion in MilliQ water. The brains were only sliced when they sank in the sucrose
solution to the bottom of the container.
Brain slicing: The perfused brains were sliced with a vibrating microtome
(model 5100MZ Campbel Instruments Ltd., UK) at a frequency of 80 Hz, 0.5mm
amplitude and 180 µm of thickness while submerged in a 6% sucrose solution.
The brain slices comprehending from the frontal origin of the lateral ventricles
to the dorsal hippocampus were mounted in glass slides. After letting the brain
slices dry slightly to ensure adherence to the slides, they were covered with
mounting medium Moviol and covered with 1.5mm glass cover.
Brain imaging and analysis: Brain slices were imaged with a Nikon Leica
microscope (Nicon Eclipse-DS-Qi2) with the 4x objective in a scale of 2.2
µm/pixel. The volume of the ventricles was calculated from the area of the
ventricles in each brain slice. The area was obtained with ImageJ and then the
volume was extracted by multiplying each area to the 180 µm of thickness of
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each brain slice. The total volume of each ventricle is the sum of the volumes
from all the brain slices of an animal. The results are expressed as the mean
of the brain ventricle volumes of all the animals from each genotype.
V.III.2 Sholl analysis
Golgi Staining: 3 months old animals were perfused transcardially with saline
(0,9% NaCl in deionized water (DW)). Then the brains were incubated in Golgi-Cox
solution for 39 h at 37◦C. After that period, they were incubated in a sucrose solution
(20% sucrose in DW) for minimum 2 days at 4◦C. Brains were sliced with a vibrating
microtome while submerged in a 6% sucrose solution while maintaining the room as
dark as possible. The slices were of 150-200 µm of thickness and mounted on 2%
gelatin-coated glass slides. After leaving the brain slices dry, the Golgi-Cox staining
was developed using this sequence:
1. DW 5 min + agitation (2x)
2. 33% ammonium hydroxyde 30min
3. DW 5 min + agitation (2x)
4. Sodium thiosulfate 1% in DW 30min
5. DW 5min + agitation (2x)
6. 50% EtOH 1min
7. 70% EtOH 1min
8. 95% EtOH 1min
9. 100% EtOH 5min (2x)
10. Solution X (1/3 chloroform + 1/3 xylene + 1/3EtOH) 15 min
11. Xylene 15 min
12. Coverslip with Moviol
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Golgi-Cox solution preparation: 5 volumes of solution A (5% w/v potassium dichro-
mate (K2Cr2O7) were mixed with 5 volumes of solution B (5gr/100ml DW Mercuric
Chloride (HgCl2) and this mix was stirred for 30 min 4 volumes of solution C (5%
w/v potassium chromate (K2CrO4) were mixed with 10 volumes of DW and gently
stirred. Then, solution C was added to the mix A+B slowly and the Golgi-Cox so-
lution (A+B+C) was stirred for 30 min in a glass bottle in the dark and incubated
for 5 days. Before using the solution, it was filtered (cellulose acetate filter 0.45µm,
Sartorius Stedim Biotech GmbH) into a new bottle.
Imaging of slices: The Golgi-stained brain slices were imaged at 4X magnification
(using an Olympus BX51 Neurolucida Microscope) to acquire the entire slice and the
specific regions in the motor and sensory cortices were imaged at 10X magnification.
For imaging the granule cells from the dentate gyrus of the hippocampus, neurons
were imaged at 40x (using a Leica SP8 Confocal Microscope). Single neurons were
analyzed using the Advanced Sholl Analysis ImageJ Plugin and the Simple Neurite
tracer ImageJ Plugin. Intersections every 5 µm were counted and plotted in the form
of line graphs. The motor and sensory cortex analysis was done on entire neurons
as well as separately on the apical and basal processes. The dentate gyrus analysis
was done on entire neurons.
V.IV Rescue experiment
The protocol was performed as detailed previously [91]. All the cages housing 7,8-
Dihydroxyflavone (DHF)-treated animals contained 2 animals/cage and the vehicle
cages consisted of 4 cages with 3 animals and 2 cages with 2. Animals of different
genotypes were mixed in the vehicle-treated cages. The DHF treatment was applied
for 4 weeks prior to the behavioural experiments and the week during which the
behavioural experiments were performed. Solution intake was monitored every 2
days and changed every 2 days. All the drinking bottles were covered with aluminium
foil for avoiding DMSO oxidation.
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V.V Statistical analysis
The statistical analysis is described in the figure legends. All data were tested for
normality (D’Agostino & Pearson test) and outliers (ROUT test). For comparing
means Student’s t-test was used for parametric data and Mann-Whitney test for non-
parametric data. 2 way RM-ANOVA test was performed to compare multiple groups
with Sidak’s post-hoc test. Statistical significance was set at P value < 0.05, using
GraphPad Prism statistical software 7.03. The experimental groups have different
sizes because the animals were tested by litters when they reached 2-3 months of
age. The amount of cKO, WT, Kidins220lox/lox and Kidins220+/+ in each test depends
on the number of animals with each genotype in the litters tested.
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[13] J. C. Arévalo, D. B. Pereira, H. Yano, K. K. Teng, and M. V. Chao, “Identifica-
tion of a switch in neurotrophin signaling by selective tyrosine phosphorylation,”
Journal of Biological Chemistry, vol. 281, no. 2, pp. 1001–1007, 2006.
[14] W. Guo, G. Nagappan, and B. Lu, “Differential effects of transient and sustained
activation of BDNF-TrkB signaling,” Developmental Neurobiology, vol. 78, no. 7,
pp. 647–659, 2018.
[15] S. Hisata, T. Sakisaka, T. Baba, T. Yamada, K. Aoki, M. Matsuda, and Y. Takai,
“Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes,
leading to sustained activation of Rap1 and ERK and neurite outgrowth,” Journal
of Cell Biology, vol. 178, no. 5, pp. 843–860, 2007.
[16] A. Bracale,* F. Cesca,* V. E. Neubrand,* T. P. Newsome, M. Way and G. Schi-
avo*, “Kidins220/ARMS Is Transported by a Kinesin-1based Mechanism Likely
to be Involved in Neuronal Differentiation,” Molecular Biology of the Cell, vol. 18,
no. 4, pp. 142–152, 2007.
[17] M. B. Kennedy, “Origin of PDZ (DHR, GLGF) domains,” Trends in Biochemical
Sciences, vol. 20, no. 9, p. 350, 1995.
[18] S. Luo, Y. Chen, K. O. Lai, J. C. Arévalo, S. C. Froehner, M. E. Adams, M. V.
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J. M. Tavaré, and P. J. Cullen, “A global analysis of SNX27-retromer assem-
bly and cargo specificity reveals a function in glucose and metal ion transport,”
Nature Cell Biology, vol. 15, no. 5, pp. 461–471, 2013.
[22] J. LIU and A. LIN, “Role of JNK activation in apoptosis: A double-edged sword,”
Cell Research, vol. 15, p. 36, 2005.
[23] M. Hamanoue, G. Middleton, S. Wyatt, E. Jaffray, R. T. Hay, and A. M. Davies,
“p75-Mediated NF-κB Activation Enhances the Survival Response of Develop-
ing Sensory Neurons to Nerve Growth Factor,” Molecular and Cellular Neuro-
science, vol. 14, no. 1, pp. 28–40, 1999.
[24] G. Middleton, M. Hamanoue, Y. Enokido, S. Wyatt, D. Pennica, E. Jaffray, R. T.
Hay, and A. M. Davies, “Cytokine-Induced Nuclear Factor Kappa B Activation
Promotes the Survival of Developing Neurons,” The Journal of Cell Biology,
vol. 148, no. 2, pp. 325 LP – 332, 2000.
[25] E. Rozengurt, “Protein Kinase D Signaling: Multiple Biological Functions in
Health and Disease,” Physiology, vol. 26, no. 1, pp. 23–33, 2011.
[26] N. Cabrera-Poch, L. Sánchez-Ruiloba, M. Rodrı́guez-Martı́nez, and T. Iglesias,
“Lipid raft disruption triggers protein kinase C and Src-dependent protein ki-
nase D activation and Kidins220 phosphorylation in neuronal cells,” Journal of
Biological Chemistry, vol. 279, no. 27, pp. 28592–28602, 2004.
[27] G. J. Fiala, I. Janowska, F. Prutek, E. Hobeika, A. Satapathy, A. Sprenger,
T. Plum, M. Seidl, J. Dengjel, M. Reth, F. Cesca, T. Brummer, S. Minguet, and
W. W. Schamel, “Kidins220/ARMS binds to the B cell antigen receptor and regu-
lates B cell development and activation,” The Journal of Experimental Medicine,
vol. 212, no. 10, pp. 1693–1708, 2015.
73
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